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Summary 
The adult mammalian brain contains neural stem cells (NSCs) that continue to generate 
neurons throughout adulthood, a process referred to as neurogenesis. Adult NSCs are 
relatively quiescent and undergo cell division only when they are activated to reenter the cell 
cycle. Two types of quiescent NSCs have been previously identified, which can be 
distinguished on the basis of differential expression of Prominin-1 (Pro). Upon activation and 
asymmetrical division, a NSC self-renews and gives rise to a transit-amplifying precursor 
(TAP), which will rapidly divide while differentiating into neuroblasts. Our group has developed 
an approach based on fluorescence activated cell sorting (FACS) to purify quiescent NSCs 
(qNSCs), activated NSCs (aNSCs) and TAPs. 
We have previously shown that in adult NSCs the orphan nuclear receptor Tailless (Tlx, 
NR2E1) is essential for promoting cell cycle entry and the transition from qNSCs to aNSCs. 
Therefore, mice lacking Tlx expression (Tlx-/-) represent a nice model system to investigate the 
mechanisms underlying NSC activation. To further understand the molecular mechanisms 
underlying the effect of TLX on NSC activation I have compared gene expression in NSCs 
isolated from wild type (WT) and Tlx-/- mice. This analysis revealed an upregulation of Hes1 
expression and a significant change in the expression of several genes associated to the 
Notch pathway in both Pro+ and Pro- mutant qNSCs. Moreover, in the absence of TLX, the 
nuclear localization of the Notch intracellular domain (NICD) was increased in Pro- qNSCs, 
suggesting hyper activation of the canonical Notch pathway, which may prevent cell cycle 
entry. To provide support for this hypothesis, I have investigated the effect of pharmacological 
inhibition of Notch signaling on NSC activation. These experiments revealed that indeed 
blockade of Notch signaling increased proliferation of both WT and Tlx-/- precursors. They also 
showed that inhibition of Notch signaling leads to the generation of Pro+ qNSCs from the Pro- 
cell pool, suggesting a lineage relationship between the two groups of qNSCs.  Since TLX is 
a transcriptional repressor, it may modulate Notch signaling by repressing the expression of 
Hes1. To further investigate this hypothesis I have taken advantage of luciferase and 
chromatin immunoprecipitation (ChIP) assays and I was able to show that TLX represses 
Hes1 expression and that this effect requires the presence of the RBPJ binding site. 
Taken together, my results have uncovered a previously unknown function of TLX in the 
regulation of Hes1 expression, which affects the activation of the canonical Notch pathway in 
NSCs and also the progression from Pro- to Pro+ qNSCs.  
 
	   	  
Zusammenfassung 
Das adulte Säugetiergehirn enthält neurale Stammzellen (NSCs), die lebenslang Nervenzellen 
bilden, ein Prozess, den man als Neurogenese bezeichnet. Die adulten NSCs befinden sich 
meist im ruhenden Zustand und teilen sich nur nach Aktivierung, um erneut in den 
Zellteilungszyklus zu  treten. Kürzlich wurden zwei Typen von ruhenden NSCs identifiziert, 
die man aufgrund der unterschiedlichen Prominin-1 (Pro) Expression unterscheiden kann. 
Nach Aktivierung und asymmetrischer Zellteilung erneuert sich die NSC selbst, und es  
entsteht jeweils eine NSC und eine Transit-Amplifying-Precursorzelle (TAP), die sich schnell 
weiterteilt und in Neuroblasten differenziert. 
Unsere Arbeitsgruppe hat eine Methode entwickelt, die auf der Fluoreszenz aktivierten 
Zellsortierung (FACS) beruht, um ruhende NSCs (rNSCs), aktivierte NSCs (aNSCs) und TAPs 
aufzureinigen. Wir haben kürzlich gezeigt, dass in adulten NSCs der 
Orphan-Nukleare-Rezeptor Tailless (TLX, NR2E1) essentiell ist für die Einleitung des 
Zellzyklus und den Übergang von rNSCs zu aNSCs. Die Tlx knockout (Tlx-/-) Maus stellt 
deshalb ein interessantes Model zur Untersuchung von Mechanismen der NSCs Aktivierung 
dar. Um zu verstehen, welche molekularen Mechanismen dem Effekt von TLX bei der NSC 
Aktivierung zugrunde liegen, habe ich die Genexpression isolierter NSCs in Wildtyp (WT) und 
Tlx-/- Mäusen verglichen.  Diese Analysen haben eine Hochregulierung der Hes1 Expression 
und eine signifikante Expressionsänderung verschiedener mit dem Notch Signalweg 
assoziierter Gene, sowohl in Pro+ als auch in Pro- mutierten rNSCs nachgewiesen. 
Darüberhinaus war bei Abwesenheit von TLX die Kernlokalisierung der Notch intrazellulären 
Domäne (NICD) in Pro- rNSCs erhöht. Dies deutet auf eine Hyperaktivierung des kanonischen 
Notch Signalweges hin, die den Eintritt in den Zellzyklus verhindert. Um diese Hypothese zu 
überprüfen, habe ich den Effekt der pharmakologischen Blockierung von Notch auf die NSC 
Aktivierung untersucht. Durch die Blockierung des Notch Signalweges zeigten die 
Experimente tatsächlich eine Proliferationszunahme sowohl in WT als auch in Tlx-/- 
Vorläuferzellen. Ich konnte ebenfalls zeigen, dass durch die Inhibierung von Notch Pro+ rNSCs 
aus dem Pro-Zellpool entstehen, was auf eine “lineage relationship” schließen lässt. Da TLX 
als Transkriptionsrepressor fungiert, kann es durch Herunterregulierung der Hes1 Expression 
Notch Signaling beeinflussen. Zur weiteren Untersuchung dieser Fragestellung habe ich 
Luziferase und Chromatin-Immunopräzipitations (ChIP) Assays eingesetzt und konnte 
nachweisen, dass TLX die Expression von Hes1 unterdrückt, wobei eine RBPJ Bindungsstelle 
notwendig ist. 
Zusammenfassend zeigen meine Ergebnisse eine bisher unbekannte Funktion von TLX bei 
der Regulation der Hes1 Expression, welche die Aktivierung des kanonischen Notch 
Signalweges in NSCs und den Übergang von Pro- zu Pro+ rNSCs beeinflusst.   
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1. Introduction 
1.1 Neurogenesis in the adult brain 
Stem cells are characterized by their capability for self-renewal and differentiation into multiple 
cell types (multi-potency). Neural stem cells (NSCs) generate the main cell types of nervous 
system, i.e. neurons, astrocytes and oligodendrocytes.  
The generation of new neurons is most active during embryonic and neonatal development. 
However, new neurons are continuously generated throughout adulthood, a process called 
neurogenesis (Altman, 1962). In the mammalian brain neurogenesis mainly occurs in two 
regions: the subgranular zone (SGZ) of the hippocampus and the subventricular zone (SVZ) of 
the lateral ventricles (Figure 1.1). 
 
Figure 1.1 Adult neurogenesis in the mammalian brain. The two neurogenic regions in the brain: the 
subventricular zone (SVZ) of lateral ventricles (LV) and the subgranular zone (SGZ) of dentate gyrus (DG) in the 
hippocampus. The Neural progenitor cells of SVZ migrate to the olfactory bulb (OB) through the rostral migratory 
stream (RMS) and differentiate into interneurons. The NSCs in the DG of the hippocampus generate granule neurons. 
A: anterior; V: ventral (Cartoon adapt from Fischer et al., 2011) 
1.2 Adult neural stem cell niche in subventricular zone 
The division and differentiation of NSCs are controlled by the microenvironment (niche). The 
neurogenic niche of the SVZ is composed by multiple elements, including cells, blood vessel 
and the cerebrospinal fluid (CSF) (Ihrie and Avarez-Buylla, 2011). As illustrated in Figure 1.2, 
the apical side of the NSCs contacts the ventricle and basal side the blood vessels. The 
ependymal cells that are located at the apical side of the SVZ provide a barrier between the 
niche and the CSF. The motile cilia of the ependymal cells maintain the flow of the CSF in the 
ventricle and express at the tip the membrane glycoprotein Prominin-1. The apical membranes 
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of ependymal cells and NSCs form a pinwheel-like structure with NSCs occupying the center 
of the pinwheel. Most adult NSCs are quiescent and extend a primary cilium into the ventricle. 
Upon activation and entry into the cell cycle NSCs retract the primary cilium. Upon cell division 
NSCs give rise to transit amplifying progenitors (TAPs), which are also referred to as type C 
cells. Unlike NSCs, TAPs proliferate very rapidly and form intermediate progenitors which 
progressively differentiate into neuroblasts (type A cells).  
  
Figure 1.2 Schematic illustration of coronary section of adult neural stem cell niche in SVZ. The top is the 
apical side of ventricle. The Ependymal (E, beige) cells are multiciliated and have motile cilia that can propel the 
cerebrospinal fluid (CSF). The Type B1 cells (dark blue) are radial glia-like quiescent NSCs which protrude a single 
primary cilium. They are in the center of a pinwheel structure formed by ependymal cells and extend an end-foot 
contact to blood vessels (Bv). The Type B2 cells (dark blue) are also radial glia-like NSCs but are proliferative and do 
not extent a primary cilium. The Type C cells (Green) are proliferative neural progenitors (TAPs), which are close to 
type B cells and also proximal to blood vessels. Type A cells (red) are neuroblasts and migrate along the rostral 
migratory stream (RMS) to the olfactory bulb. (Cartoon adapted from Ihrie and Avarez-Buylla, 2011 with modification) 
Besides the morphological differences, the various cell types in the niche also express 
different markers. As summarized in Figure 1.3, the radial glia-like (with a cell body contacts 
the ventricles and a long radial process extending to the pial surface of the brain) quiescent 
NSCs (qNSCs) are both Prominin-1 (CD133) and Glial fibrillary acidic protein (Gfap) positive 
(Codega, et.al, 2014). Activated NSCs (aNSCs) express in addition the epidermal growth 
factor receptor (Egfr) at the cell membrane (Carrillo-Garcia et al., 2010; Obernier et al., 2011). 
whereas TAPs lack the expression of both Prominin-1 and Gfap but are still Egfr 
immunopositive when they differentiate into neuroblasts they lose their Egfr identity 
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(Carrillo-Garcia et al., 2010). Besides in NSCs, Gfap is also expressed in niche astrocytes and 
in a population of radial glia-like qNSCs, which lack the expression of Prominin-1 (Fischer et 
al., 2011; Codega et.al, 2014). Nestin is specifically expressed in neuro-epithelial stem cells 
(Lendahl et al., 1990) and is widely used as an NSC marker in mouse brain (Imayoshi et al., 
2011). Many groups are using the Nestin-GFP or Gfap-GFP transgenic mice to mark the 
NSCs in the brain. However, different transgenic lines could yield different results because of 
the different genetic background caused by variable insertion site of the reporter gene (Fischer 
et al., 2011). Our group has developed a Fluorescence Activated Cells Sorting (FACS) 
approach to separate NSCs and their progeny without using transgenic lines. However, 
because of the lack of unique markers, NSCs and their progeny can be distinguished only by 
co-detection of multiple markers. For example, taking advantage of the two cell surface marker 
Prominin-1 (P) and Egfr (E), we could separately isolate qNSCs (P+Elow), aNSCs (P+Ehigh), 
TAPs (P-Ehigh) and neuroblasts (P-Elow) from the neonatal and adult SVZ (Carrillo-Garcia et al., 
2010; Obernier et al., 2011; Khatri et al., 2014). 
  
Figure 1.3 The cellular markers for SVZ stem cells and their progeny. Quiescent NSCs are Prominin-1 (CD133) 
positive and express Egfr at low levels. Activated NSCs are Prominin-1 positive and highly Egfr positive. TAPs are 
negative for Prominin-1 but still high express Egfr. Neuroblasts are Prominin-1 and Egfr negative. Of note, a subset of 
quiescent NSCs are also Prominin-1 negative but Gfap positive and to be distinguished from niche astrocytes through 
absence of extended processes. (Cartoon adapted from Codega et al., 2014)  
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1.3 The orphan nuclear receptor TLX and neurogenesis 
Tlx (Tailless, NR2E1) was first identified in a screening of drosophila development mutants 
(Pignoni et al., 1990). The Tailless (tll) drosophila mutant has abnormalities in the terminal 
abdominal segment as well as in part of head structures and brain. The mouse Tlx gene was 
cloned by Monaghan et al., using the drosophila tll gene as template. The drosophila tll gene 
and its mouse homologue gene Tlx both code for a conserved orphan nuclear receptor 
specifically expressed in the eye and in the forebrain. During development of the mouse 
central nervous system (CNS) the TLX protein is detectable in the telencephalon, 
diencephalon, retina and olfactory placode (Yu et al., 1994; Monaghan et al., 1995). The 
expression of Tlx begins at embryonic day 8 (E8), peaks at E12.5, and then decreases from 
E13.5 until birth (Monaghan et al., 1995). After birth Tlx expression increases again to reach 
high expression levels in the adult brains. Tlx-/- mice appear normal at birth (Monaghan, et al., 
1997). However, compared to the WT counterparts, adult mutant mice have severely reduced 
hippocampal dentate gyri, greatly expanded lateral ventricles and declined olfactory bulbs, 
indicating an impairment of neurogenesis (Monaghan et al., 1997; Shi et al., 2004) (Figure 
1.4a). Moreover, Tlx-/- mice are more aggressive especially in males and therefore difficult to 
breed and handle. Taking advantage of a beta-galactosidase (beta-gal) reporter under the 
control of Tlx promoter, Shi et al. examined the expression pattern of Tlx in adult brains of 
heterozygote mice (Figure 1.4b). The reporter was found at high and dispersed pattern in the 
subgranular layer of the hippocampus DG as well as in a clustered pattern in the SVZ (Shi et 
al., 2004). All together, the highly enriched expression in the wild-type (WT) brain and the 
histological defects and behavior disorders of the Tlx-/- mice suggest that TLX plays an 
important role in neurogenesis and function of the brain. 
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Figure 1.4 The Tlx expression pattern in the mouse SVZ. The histological observation of adult brains sections of 
both WT and Tlx-/- mice by Nissl staining (a). The beta-galactosidase (b-gal) reporter gene under control of the Tlx 
promoter was knocked in into the Tlx locus of Tlx-/- mice. The Tlx expression pattern (b) was shown in DG and SVZ of 
the adult heterozygouse Tlx+/- brain by LacZ staining (blue dots). (Figure adapted from Shi et al., 2004) Abbreviations: 
DG, dentate gyri; SVZ, subventricular zone; OB, olfactory bulb. 
By using a TLX-specific antibody, Li et al. showed that TLX is expressed in both qNSC and 
TAPs in the SVZ of adult mouse brains (Li et al., 2012), which was consistent with our previous 
analysis of Tlx mRNA expression (Obernier et al., 2011). Loss of Tlx leads to a dramatic 
decrease in proliferation as shown by reduced BrdU incorporation and retention after pulse 
chase (Li et al., 2012). In fact, we found that, compared to the WT counterpart, activated 
aNSCs and TAPs are both reduced whereas the percentage of qNSCs increases in the Tlx-/- 
niche. Together these both findings underscored that TLX plays a key role in the regulation of 
NSC activation.  
TLX mostly acts as a transcriptional repressor recruiting histone deacetylases (HDAC3 and 
HDAC5) to the promoters of its target genes, such as p21 and Pten (Sun et al., 2007). 
However, TLX also activates the transcription of target genes such as the proneural factor 
Mash1 by directly binding at its Sp1 consensus sequence (Elmi et al., 2010). Moreover, TLX 
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has been shown to regulate neurogenesis through coordination of several signaling pathways 
according to the RNA-seq data (Niu et al., 2011). TLX activates Wnt7a/Beta-catenin signaling 
to stimulate NSC proliferation and self-renewal (Qu et al., 2009). In addition, Tlx can also be 
regulated by several mechanisms. For example, it was shown that MicroRNA-9 and 
MicroRNA-137 form a regulatory loop with Tlx and regulate the balance of NSC proliferation 
and differentiation (Zhao et al., 2009; Sun et al., 2011). MicroRNA let-7b and let-7d could also 
negatively regulate Tlx expression by targeting its 3’UTR (3’ Untranslated region) (Zhao et al., 
2010; Zhao et al., 2013). Interleukin-1β (IL-1b), which is the most predominant 
pro-inflammatory cytokine in the brain, could also negatively regulate Tlx expression (Ryan et 
al., 2013). All these data suggest that Tlx coordinates NSC proliferation and differentiation. 
1.4 Notch signaling in the neurogenesis of the adult brain 
The canonical Notch signaling is dependent on cell-cell contact and its activation needs the 
binding of a ligand from a donor cell to the Notch receptor of a signal-receiving cell (Figure 1.5) 
(Ables et al., 2011). Upon binding its ligand and proteolytic cleavage by the γ-secretase, the 
intracellular domain of Notch (NICD) is translocated into the nucleus where it interacts with the 
DNA-binding protein CSL (CBF1/RBPjκ/Su(H)/Lag-1) (Kopan et al., 2009; Ables et al., 2011). 
In the absence of NICD, CSL is associated with ubiquitous corepressor (Co-R) proteins and 
histone deacetylases (HDACs) to repress transcription of target genes. Upon NICD binding, 
transcriptional repressors are replaced by transcriptional coactivator Mastermind (MAM) and 
the transcription of downstream genes are activated. In mammals there are four different 
Notch receptors (Notch1, Notch2, Notch3, Notch4). And the five ligands are the Delta-like (Dll1, 
3, 4) and Jagged (Jag1, 2) proteins. The typical Notch target genes are members of the Hes 
(such as Hes1 and Hes5) and Hey families. These target genes encode inhibitory basic 
helix-loop-helix (bHLH) proteins, which heterodimerize with bHLH activators such as NGN2 
and MASH1 thereby inhibiting neuronal differentiation. As a feedback mechanism, proneural 
genes Ngn2 and Mash1 could also induce Delta expression, thereby activating Notch 
signaling and inhibiting neuronal differentiation of neighbor receiving cells (Kageyama et al., 
2007). 
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Figure 1.5 Schematic of canonical Notch signaling. The transduction of Notch signaling is based on the cell-cell 
interaction, which includes a ‘signal-sending cell’ that presents the Notch ligand and a ‘signal-receiving cell’, which 
expresses the Notch receptor. The activation of Notch signaling is triggered by the interaction of the ligand to the 
receptor. Upon activation, the Notch receptor is cleaved by γ-secretase and the Notch intracellular domain (NICD) is 
released and translocated into the nucleus. Thereafter, NICD replace the repressor complex on recombining binding 
protein suppressor of hairless (RBPJ or CSL) with a co-activator and initiate transcription of Notch target genes. 
(Cartoon adapted from Ables et al., 2011) 
Because they are key effectors of the canonical Notch signaling, members of the Hes genes 
family have been intensively investigated in mutant mice. Knockout of Hes1 and Hes5 caused 
a premature neuronal differentiation and the severity of the phenotype was enhanced in 
Hes1/Hes5 double knockout mice indicating the functional redundancy of these two genes 
(Ohtsuka et al., 1999). As a consequence of a negative feedback, Hes1 is expressed in an 
oscillatory fashion with two hours periodicity, what may indicate that it regulates the timing of 
many biological processes (Hirata et al., 2002). However, Hes1 is constitutively expressed in 
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boundary cells, which are not proliferating. In accordance to that, the proliferation of 
telencephalic neural progenitor cells is reduced when Hes1 is overexpressed (Baek et al., 
2006), indicating that Hes1 may have an important role for regulating the cell cycle exit or 
maintenance of quiescence.  
Normal brain development requires proper timing of differentiation programs. The Notch 
signaling is a key pathway in this regulation as it can modulate NSCs and neural development 
both spatially and temporally (Ables et al., 2011; Koch et al., 2013). Moreover, the components 
of Notch signaling are expressed throughout the adult brain, which suggests that Notch plays 
a role also in brain function (Berezovska et al., 1998). Notch regulates the cell cycle in order to 
control the balance of NSC maintenance and differentiation. The progenitors can be driven 
into quiescence by Notch induction, whereas the NSC division reinitiates upon blocking Notch 
(Chapouton et al., 2010). Knockout of Notch signaling components can deplete the NSC pool 
and increase the early progenitor cells. More intriguingly, the relative levels of Notch activity in 
NSCs can regulate the opposing states of quiescence versus proliferation. Low level of NICD 
leads to proliferation and high level causes growth arrest (Guentchev et al., 2006). However, 
the neuronal committed progenitors are less dependent on Notch and more responsive to 
environmental cues for the regulation of proliferation, suggesting that the capacity of Notch to 
regulate proliferation in the adult brain is cell type or cellular context dependent (Albes et al., 
2010). As another layer of complexity, many of the Notch receptors have redundant roles, 
such as Notch3 may partially compensate the function of Notch1 receptor knockout mice 
(Mason et al., 2005). Furthermore, it has been recently determined that Notch signaling can be 
activated without ligands or the interaction with CSL which referred to as ‘non-canonical’ 
signaling (Andersen et.al, 2012). Therefore, neurogenesis is more intricately regulated by 
Notch signaling. 
1.5 The aim of the work  
The neurogenesis in the adult mammalian brain provides an important source of neurons for 
cell replacement therapies of the damaged brain. Although most of the adult NSCs are 
relatively quiescent, the investigation of the molecular mechanisms underlying their activation 
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would greatly benefit the clinical application. Previous research in our lab has found that Tlx is 
highly expressed in proliferative activated NSCs and TAPs and revealed a concomitant 
increase of Notch signaling target gene Hes1 in activated NSCs (Obernier et al., 2011). Since 
neurogenesis is impaired in Tlx knockout (Tlx-/-) mice, this model is suitable to investigate the 
mechanisms of NSC activation.  
To understand the molecular mechanisms underlying the effect of TLX on NSC activation, my 
thesis will focus on: 
1) Gene expression profile analysis of Notch signalling genes in NSCs isolated from age 
matched wild-type (WT) and Tlx knock-out/LacZ knock-in mice (Tlx-/-).  
2) Pharmacological inhibition of Notch signalling and loss of function approaches of Hes1 on 
NSC activation in both WT and Tlx-/- mice.  
3) Molecular biological analysis of TLX and Hes1 interaction by reporter assays and chromatin 
immunoprecipitation (ChIP) to investigate whether TLX modulates Hes1 gene transcription. 
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2. Materials and methods 
2.1. Materials  
2.1.1. General reagents  
Reagents Company 
NP-40  CN Biomedicals Inco. 
Ammonium chloride Merck 
Glycine Life Technologies 
Paraformaldehyde Fluka 
Isopropanol  Applichem 
Mowiol Calbiotech 
Low Melting Agarose Life Technologies 
Ethanol Sigma 
Fetal bovine serum Gibco 
DPBS Life Technologies 
 
Equipments 
 
Company 
FACS BD Aria II 
Centrifuge Eppendorf 
4D Nucleofector System Lonza 
Real-time PCR System ABI 7300 
Microplate Luminometer GloMax 96  
Spectrophotometer Pharmacia Biotech Ultraspec 300 
Confocal Microscopy Leica SP2 
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2.1.2. Plasmids  
pFUGW  (Lois et al., 2002) 
pFUGW-Tlx(Constructed by Kirsten Obernier) 
pLentilox3.7(Rubinson et al., 2003) 
EF.mHES1.Ubc.GFP(Yu et al., 2006) 
pCAGGS-NICD1(Dang et al., 2006) 
pHes1(467)-luc (Nishimura et al., 1998) 
pHes1-RBPJ(-)-Luc (Nishimura et al., 1998) 
pHes5-Luc (Nishimura et al., 1998) 
pRBPJ-AdTATA-Luc or p10XCBF1-luc (Mckenzie et al., 2006) 
pAdTATA-Luc (Mckenzie et al., 2006) 
pGL4.83[hRlucP/Puro]-EF1a-hRlucP (From Priit Pruunsild of Bading Group, IZN-Neurobiology, 
University of Heidelberg)  
Lentivirus second generation packaging system plasmids: 
pCMVdelta8.9 (Packaging plasmid) (Zufferey et al., 1997) 
pVSVG (Envelope plasmid) (Naldini et al., 1996) 
Lentivirus third generation packaging system plasmids:  
(Dull et al., 1998) 
pMDlg/pRRE (Packaging plasmid) 
pRSV-Rev (Packaging plasmid) 
pMD2.G (Envelope plasmid) 
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Adeno-associated virus (AAV) 2/1 packaging system plasmids: 
pFdelta6   
pRVI    
pH21 (Hauck et al., 2003)  
2.1.3. Reagents for DNA cloning 
2.1.3.1 Primers and oligonucleotides 
1. Sub-cloning primers of LentiLox3.7-Hes1-shRNA 
Underlined letters are shRNA sequence specific for Hes1 mRNA, the Italic letters are 
restriction endonuclease recognization sequence and the bold letters are backbone to form 
stem and loop of shRNA. [shRNA sequence from (Kobayashi et al., 2009)] 
1) Hes1-KD1 shRNA 
Forward primer 
5’ AAC G GCCAATTTGCCTTTCTCATCC TTCAAGAGA GGATGAGAAAGGCAAATTGGC CTTTTTT C 3’ 
Reverse primer   
5’ TCGAG AAAAAAG GCCAATTTGCCTTTCTCATCCTCTCTTGAA GGATGAGAAAGGCAAATTGGC C GTT 3’ 
2) Hes1-KD2 shRNA 
Forward primer 
5’ AAC G GTAGAGAGCTGTATTAAGTGA TTCAAGAGA TCACTTAATACAGCTCTCTAC CTTTTTT C 3’ 
Reverse primer   
5’ TCGAG AAAAAAG GTAGAGAGCTGTATTAAGTGA TCTCTTGAA TCACTTAATACAGCTCTCTAC C GTT 3’ 
2. Sub-cloning primers of pAAV-U6-Hes1-shRNA-CBA-GFP 
1) Hes1-KD1 shRNA 
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Forward primer 
5’ GATCC CC GCCAATTTGCCTTTCTCATCC TTCAAGAGA GGATGAGAAAGGCAAATTGGCTTTTTGGAA A 3’ 
Reverse primer 
5’AGCTT TTCCAAAAA GCCAATTTGCCTTTCTCATCC TCTCTTGAA GGATGAGAAAGGCAAATTGGCGG G 3’ 
2) Hes1-KD2 shRNA 
Forward primer 
5’GATCC CC GTAGAGAGCTGTATTAAGTGA TTCAAGAGA TCACTTAATACAGCTCTCTAC TTTTTGGAA A 3’ 
Reverse primer 
5’AGCTT TTCCAAAAA GTAGAGAGCTGTATTAAGTGA TCTCTTGAA TCACTTAATACAGCTCTCTAC GG G 3’ 
3) Sequencing primer 
Reverse sequencing primer (300bp downstream of the insertion site) 
GAT GGG GAG AGT GAA GCA GA 
4) WPRE sequence for quantify the AAV titration 
Forward primer: ACTGTGTTTGCTGACGCAAC 
Reverse primer: CAACACCACGGAATTGTCAG 
5) Screening primers for the insertion of Hes1 shRNA into Lentilox3.7 
Forward: CAGCACAAAAGGAAACTCAC 
Reverse: GCGGTAATACGGTTATCCAC 
Product: 238bp, with insertion: 320bp 
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2.1.3.2 Reagents and kits for DNA cloning 
Reagents or Kits Company 
HpaI, XhoI, NheI. NEB 
Phusion High-Fidelity DNA Polymerase NEB  
T4 DNA ligase and ATP Thermo Scientific 
PureLink® HiPure Plasmid Filter Maxiprep Kit Life Technologies 
QIAquick® Gel Extraction Kit QIAGEN 
QIAquick® PCR Purification Kit  QIAGEN 
QIAprep® Spin Miniprep Kit  QIAGEN 
2.1.4 Reagents for cell culture and transfection and viral preparation 
Reagents Company 
StemPro® Accutase Cell Dissociation 
Reagent 
Life Technologies 
Trypsin-0.05%EDTA  Gibco 
EGF Peprotech  
huFGF2 Peprotech  
B27 supplement Gibco 
DMEM, high glucose Gibco 
L-Glutamine 200 mM Gibco 
Penicillin/Streptomycin  Gibco 
PI (propidium iodide)  Sigma 
DNase I  Sigma 
Ovomucoid  Sigma 
Papain  Sigma 
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Euromed-N medium  Euroclone  
Leibovitz's L-15 Medium Gibco 
Neurobasal-A Medium Gibco 
DAPT Sigma 
peqFECT DNA Transfection Reagent peqlab 
D-(+)-Glucose 45% Sigma 
Iscove's Modified Dulbecco's Medium(IMDM) Life Technologies 
Sodium Deoxycholate Sigma 
Benzonase Sigma 
HiTrap Heparin Column Amersham 
Amicon Ultra-4 Centrifugal Filter Millipore 
2.1.5 Antibodies 
Primary Antibodies Company Dilution 
Prominin-conjugated PE Molecular probes  1:100-1:400 
EGF-conjugated Alexa 647  Molecular probes  1:1000 
Anti-NR2E1 Rabbit IgG LifeSpan BioSciences, Inc. 1:100 for ChIP 
Mash1 Mouse IgG BD-Pharmingen 1:200 
Ki67 Rabbit IgG Abcam 1:500 
NICD1 Rabbit IgG Abcam 1:400 
GFAP mouse IgG1 Sigma 1:1000 
 
Secondary Antibodies 
 
Company 
 
Dilution 
Mouse IgG-488 Mol.Probes 1:1000 
Mouse IgG-cy3 Mol.Probes 1:500 
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Rabbit IgG-488 Mol.Probes 1:1000 
Rabbit IgG-cy3 Mol.Probes 1:200 
DAPI (1 mg/ml) Sigma 1:1000 
2.1.6 Reagents for RT-qPCR, luciferase assay and chromatin 
immunoprecipitation (ChIP) 
Reagents or Kits Company 
TaqMan®
 
Universal PCR Master Mix (2x)  Life Technologies 
Arcturus®
 
PicoPureRNA Isolation Kit  Life Technologies 
RNeasy Micro or Mini Kit Qiagen 
Dual-Glo® Luciferase Assay System  Promega 
Dynabeads® Protein G for 
Immunoprecipitation 
Life Technologies 
M-MLV Reverse Transcriptase Promega 
Oligo(dT) 15 primer  Promega 
TaqMan® Universal PCR Master Mix Life Technologies 
Power SYBR® Green PCR Master Mix Life Technologies 	  
Probes for Taqman qRT-PCR  
Actb Mm00607939_s1 
Ascl1 (Mash1) Mm04207567_g1 
Hes1 Mm01342805_m1 
Notch3 Mm01345646_m1 
Hes5 Mm00439311_g1 
Notch1 Mm00435249_m1 
Dll1 Mm01279269_m1 
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RBPj Mm03053645_s1 
2.1.7 Animals and cell lines 
Both neonatal (p7) and adult (8 weeks) of WT and Tlx-/- mice are C57BL/6 genetic background. 
HEK293FT: established from human embryonic kidney cells transformed with the SV40 large 
T antigen (Life Technologies). 
2.2 Methods 
2.2.1 DNA cloning 
2.2.1.1	  Sub-cloning of LentiLox3.7-Hes1-shRNA  
	  
Figure 2.1 Schematic overview of LentiLox3.7 backbone for sub-cloning of Hes1 shRNA.  
The Hes1 shRNA was cloned into the LentiLox3.7 by two restriction sites HpaI and XhoI which is under the control of 
U6 promoter. The EGFP (enhanced Green Fluorescent Protein) is driven by CMV promoter and followed by 
Woodchuck Hepatitis Virus posttranscriptional Regulatory Element (WPRE). The primers for amplifying the insert are 
also indicated as screen F and screen R. 
1. Oligonucleotide designing strategy 
1) Restriction enzyme sites 
Two restriction enzyme sites were included in the oligonucleotide sequence of each shRNA 
according to the MIT protocol. 
HpaI: GTT/AAC blunt end at 5’ 
XhoI: C/TCGAG sticky end at the 3’  
2) Oligonucleotide format 
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Sense oligonucleotide: 5’AAC-(GN21)-(TTCAAGAGA)-(12NC)-TTTTTT-C3’ 
Antisense oligonucleotide: 5’ TCGAG-AAAAAA-(GN21)-(TTCAAGAGA)-(12NC)- GTT 3’ 
The shRNA loop sequence (TTCAAGAGA) is based on the method of the paper 
Brummelkamp et al., Science, 2002.The two oligonucleotides were ordered through Eurofins 
with salt free purification. 
2. Protocol (modified from the original MIT protocol) 
1) The primers were annealed to obtain double strand shRNA with XhoI and HpaI restriction 
nuclease sites. 
2) The LentiLox3.7 vector was cut with XhoI and HpaI and the digested fragments were 
separated by gel electrophoresis. Then the desired bands were purified with the Gel Extraction 
Kit. 
3) The LentiLox3.7 backbone and Hes1-shRNA were ligated together with T4 ligase. 
4) The ligation product was transformed into stlb3 competent E. coli and cultured with 
ampicillin selection at 37oC. 
5) Around 10 colonies were picked up and incubated at 37oC for 2 hours and then the insertion 
of shRNA was checked by PCR.  
6) The insertion of shRNA was confirmed by HpaI and NotI double restriction enzymes 
digestion. And there was a band shift of 70bp of positive cloning by 2% agrose gel compared 
to the lentiLox3.7 vector. 
7) The shRNA insertion was sequenced by primer corresponding to FLAP (cagtgcaggggaa 
agaatagtagac) and the sequencing was conducted by GATC Biotech. 
3. Solutions in the protocol  
1). Annealing solution 50 µl Total 
Sense Oligo (60 µM) 1 µl 
Antisense Oligo (60 µm) 1 µl  
ddH2O 48 µl 
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The solution was incubated at 95oC 4 min, 70oC 10 min, cooled down at RT and stored at 4oC. 
2). Restriction digestion  20 ul Total 
pLentilox3.7 2 µg 
10XBuffer 2 µl 
XhoI 1 µl 
HpaI 1 µl 
ddH2O Add to 20 µl in total 
The digestion was conducted at 37oC water bath for 1-2 h and stopped by incubating it at 65oC 
for 10 min. 
3). Ligation  10 µl total 
pLentiLox3.7 backbone 60 fmol 
Annealed oligo 60 fmol 
T4 Ligase 1 µl 
10X T4 Ligase buffer 1 µl 
ATP (100 mM) 0.5 µl 
ddH2O Add to 10 µl in total 
The backbone and the oligonucleotides were ligated at RT for 1 h and the ligation was stopped 
by incubating at 65oC for 10 min. 
2.2.1.2	  Sub-cloning of pAAV-U6-Hes1-shRNA-CBA-GFP  
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Figure 2.2 Schematic overview of pAAV-U6-CBA-GFP backbone for sub-cloning of Hes1 shRNA.  
The Hes1 shRNA was cloned into the pAAV-U6-CBA-GFP by two restriction sites BamHI and HindIII which is under 
the control of U6 promoter. The hrGFP (humanized recombinant Green Fluorescent Protein) is driven by CBA 
(chicken beta-actin) promoter and followed by Woodchuck Hepatitis Virus posttranscriptional Regulatory Element 
(WPRE) and bGH (bovine growth hormone) polyA signal.  
1) Restriction enzyme sites 
Two restriction enzyme sites are included when synthesize the oligos of shRNA  
BamHI: G/GATCC at 5’ end  
HindIII: A/AGCTT at 3’ end  
2) Oligonucleotide format 
Sense oligonucleotide: 5’GATCC-CC-(GN21)-(TTCAAGAGA)-(12NC)-TTTTTGGAA-A3’ 
Antisense oligonucleotide: 5’ AGCTT-TTCCAAAAA-(GN21)-(TTCAAGAGA)-(12NC)- GG-G 3’ 
The protocol is same as the subcloning of pLentilox-3.7-Hes1-shRNA just with two different 
restriction enzymes BamHI and HindIII. And the sequencing primer is a reverse primer located 
in the WPRE element (GAT GGG GAG AGT GAA GCA GA). 
2.2.2 Cell culture and virus production 
2.2.2.1 HEK293FT cell culture  
The HEK293FT cells were used for producing lentivirus or adeno-associated virus. The cells 
were cultured in 10 cm tissue culture dishes with DMEM complete medium. The cells were 
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passaged every 2-3 days with a splitting ratio of 1:4. During passage, the culturing medium 
was removed and the cells were gently washed twice with 0.1 M phosphate buffered saline 
(PBS). And 0.5 ml Trypsin-EDTA (0.05%) was added directly onto the cells after removing 
PBS, and the dish was incubated at 37oC for 1 min. And then, 2 ml DMEM-complete medium 
was added into the dish to stop the enzyme digestion. Cells were dissociated into single-cell 
suspension by pipetting 3-5 times and collected in a 15 ml falcon tube. The cell suspension 
was spun down at 800 g for 2 min to remove the supernatant. The cells were aliquoted into 
new dishes with prewarmed DMEM complete medium.  
DMEM complete medium  
DMEM, high glucose (4.5g/L) 500 ml 
Heat-inactivated FBS# 50 ml 
Pen/Strep 2.5 ml 
                               # FBS was inactivated at 56oC for 30 min. 
2.2.2.2 Lentivirus production and purification 
2.2.2.2.1 Lentivirus production 
1. The 3X106 HEK293FT cells were pre-seeded in a 10 cm dish the previous day in order to 
get 80% confluence before transfection; 4X10 cm dishes were prepared for each virus. 
2.The following plasmids were mixed in 450 µl ddH2O in a 15 ml tube. 
                   For each 10 cm dish 
pHCMVG 6 µg 
pMDLg/pRRE 10 µg 
pRSV-Rev 5 µg 
Virus plasmid 20 µg 
3. The 50 µl 2.5 M CaCl2 was added into the mixture prepared last step and mixed well. 
4. Then 500 µl 2XHeBS was added dropwise to the mixture while shaking the tube to 
thoroughly mix the two solutions. 
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5. The solution was incubated at RT for 30 min before being added onto the cells. 
6. After 6 hours the supernatant was replaced with fresh medium. Thereafter, the supernatant 
was collected at the time point of 48 h and 72 h after transfection and stored at 4oC before 
purification. 
2XHeBS  
HEPES 50 mM 
NaCl 280 mM 
Na2HPO4 1.5 mM 
2.2.2.2.2 Lentivirus purification by Abm speedy lentivirus purification kit 
1. The viral supernatant was spun at 2500 g for 10 min and filtered through a 0.45 µm PVDF 
syringe filter to get rid of cell debris. 
2. Then 5 ml lenti-binding solution was added into 45 ml viral supernatant and mixed 
completely by turning upside down the tube several times. 
3. The mixture was centrifuged at 5000 g for 30min at 4oC and then the supernatant carefully 
disposed without disturbing the pellet. 
4. The viral pellet was resuspended in 3.5 ml DPBS solution and loaded into an Amicon Ultr-4 
centrifugal filter unit. 
5. The loaded filter unit was centrifuged at 5000 g for 10min and washed twice with DPBS. And 
the virus was reconstituted in 100-300 µl DPBS. The virus was aliquoted into 20 µl each tube 
and stored at -80oC.  
2.2.2.2.3 Titering of lentivirus 
1. The 3X104 HEK293FT cells were seeded in each well of a 96-well plate 24 hours before 
titration. 
2. The original viral stock was diluted up to 106 times by serial 10-fold dilutions. 
3. The infected cells were cultivated at 37oC for 48 h to express the GFP tag. 
4. The GFP positive cells were counted under the fluorescence microscope and the titration 
was calculated by the formula below: 
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Titer (TU/mL)= GFP+ cell number/virus volume. 
5. The titer could also be measured by using FACS to analyze the percentage of GFP+ cells. 
Titer (TU/mL)= (GFP+ cell) % X total seeded cell Number/virus volume. 
2.2.2.3 Adeno-associated virus production and purification 
2.2.2.3.1 Adeno-associated virus production 
For each AAV virus, the HEK293 cells in 5X14 cm dishes were transfected. 
1. The medium in 14 cm dishes was replaced with 25 ml pre-warmed IMDM 2 h before 
transfection. 
2. The transfection mixture was prepared by adding ingredients into a 15 ml tube in the 
following order: ddH2O, CaCl2, plasmids: 
 
ddH2O 12 ml 
 
2.5 M CaCl2 1.65 ml 
 
AAV plasmid 62.5 µg 
 
pFdelta6 125 µg 
 
pRVI 31.25 µg 
 
pH21 31.25 µg 
 
3. After preparing the mixture, 13 ml 2XHeBS was added dropwise while shaking the tube to 
thoroughly mix the two solutions. 
4. The transfection solution was added dropwise onto the cells and mixed by swirling gently. 
5. The cells were incubated at 37oC. After six hours the medium was replaced with DMEM 
complete medium and plates were returned to the incubator for further 60 hours. 
2.2.2.3.2 AAV purification 
1. Harvest the cells 60-65 h later 
Materials and methods 
	   24 
1) The cells were washed gently with 0.1 M PBS twice and detached by cell scraper. 
2) The cells were centrifuged at 800 g for 5 min to obtain the cell pellet. 
3) The pellets were pooled together from 5X14 cm dishes and resuspended in 50 ml 150 mM 
NaCl/20 mM Tris solution. 
4) Thereafter the cell suspension was aliquoted into two 25 ml lots in 50ml tube and frozen at 
-20oC overnight. 
2. Benzonase treatment to remove cellular DNA and RNA 
1) The fresh 10% sodium deoxycholate solution was prepared in H2O.  
2) Then 1.25 ml 10% sodium deoxycholate was added to each 25 ml cell suspension (for a 
final concentration of 0.5%) along with 5.10 ml 250 U/ml benzonase (for a final concentration 
of 50 U/ml). 
3) The solutions were mixed completely and incubated in a 37°C water bath for 1 h. 
4) The mixture was centrifuged at 3000 g for 15 min at 4°C and the supernatant was 
transferred into a new tube. (Stored at –20°C until column purification) 
3. Heparin column purification 
1) The heparin column was pre-equilibrated with 10 ml 150 ml NaCl/20 mM Tris solution at a 
flow rate of 1 ml/min. 
2) The 50 ml virus supernatant was loaded into a 60 ml syringe and washed through the 
column at a flow rate of 1 ml/min. 
3) Then the column was washed with 20 ml 100 mM NaCl/20 mM Tris at a flow rate of 1 ml/min 
by using a 60ml syringe. 
4) The column was washed with 1 ml 200 mM NaCl/20 mM Tris and 1 ml 300 mM NaCl / 20 
mM Tris solutions, respectively.  
5) The virus then was eluted into a sterile 15 ml tube with1.5 ml 400 mM NaCl/20 mM Tris, 3.0 
ml 450 mM NaCl/20 mM Tris and 1.5 ml 500 mM NaCl/20 mM Tris solutions respectively. 
6) The virus was concentrated with Amicon Ultra-4 filter by centrifuging at 2000g for 3 min 
followed by washing with 3.5 ml DPBS twice. 
Materials and methods 
	   25 
7) The virus was concentrated on the filter (around 250 ul). The concentrated virus then was 
filtered through a 13 mm, 0.2 µm syringe filter and stored at -20oC. 
2.2.2.3.3 AAV genomic tittering 
1. Extraction of viral DNA 
1) The viral stock was digested by DNase I to remove non-viral DNA by incubating at 37°C for 
30 min 
Virus 2 µl 
10X DNase buffer  10 µl 
DNase I (Life Technologies)  1 µl 
ddH2O 86 µl 
2). The Dnase I activity was stopped by incubating the solution at 70°C for 10 min followed by 
adding 1µl proteinase K and incubating at 50°C for 1 h to remove the viral capsid and protein.  
3). The Proteinase K was inactivated by incubating at 95°C for 20 min and the viral DNA was 
stored at 4°C before genomic tittering. 
2. Genomic titration 
1). A serial of dilutions of a reference plasmid were prepared at 1010,109,108,107, 106, 105, and 
104 copies/ml for standard curve and ddH2O was included for non-template control.  
2). A master mix was prepared as below and the tittering was analyzed with qPCR 
Master Mix 20 µl total 
Sense primer (10µM) 0.4 µl 
Antisense primer (10µM) 0.4 µl 
Sybr Green Mix (2X) 10 µl 
ddH2O 8.2 µl 
Viral DNA or Reference plasmid 1 µl 
3). The titre was calculated by multiplying the qPCR production concentration with 105 for viral 
particles per ml. 
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2.2.3 SVZ dissection and FACS 
1. NSA complete Total 10 ml 
NS-A medium 9.8 ml 
L-Glutamine 200 mM 100 µl 
Pen/Strep 100 µl 
2. E/F Medium Total 10 ml 
NSA Complete 10 ml 
B27 Supplement 200 µl 
huFGF-2 (Stock 20 µg/ml) 5 µl (Final 10 ng/ml) 
huEGF recom (Stock 20 µg/ml) 10 µl (Final 20 ng/ml) 
3. Sort medium Total 10 ml 
NSA complete 5 ml 
Leibowitz L15 Medium 5 ml 
B27 supplement 200 µl 
FBS 100 µl 
D-(+)-Glucose 45% 133 µl 
huFGF-2 (Stock 20 µg/ml) 5 µl 
DNAse (Stock 0.1% in ddH2O) 100 µl 
4. NBA collecting medium Total 10 ml 
Neural Basal A medium 9.8 ml 
L-Glutamine 200 mM 100 µl 
Pen/Strep 100 µl 
B27 supplement 200 µl 
huFGF-2 (Stock 20 µg/ml) 5 µl 
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5. Dissection solution (pH 6.9) Dissolved in ddH2O and filter to 
sterile 
150 mM Sucrose 
125 mM NaCl 
3.5 mM KCl 
1.2 mM NaH2PO4 
2.4 mM CaCl2·2H2O 
1.3 mM MgCl2·6H2O 
0.1%(6.65 mM) Glucose 
2 mM Hepes 
6. Papain stock solution 2X Dissolved in 60 ml 0.1 M PBS and 
filter to Sterile 
Papain 100 mg 
L-Cystein 20 mg 
EDTA 20 mg 
7. Ovomucoid stock solution 2X Prepared in 0.1 M PBS and filter to 
Sterile 
Trypsin Inhibitor 1.4 mg/ml 
2.2.3.1 SVZ dissection and dissociation 
SVZ tissues were obtained from the brain of postnatal 7 days mice (p7) or 8 weeks old adults 
of Tlx line. P7 mice were killed by decapitation and the adults were killed by neck dislocation 
after the CO2 anesthesia in accordance with the ethical guidelines for the care and use of 
laboratory animals (Karlsruhe, Germany). The SVZ was dissected in ice-cold sucrose 
dissection solution and dissociated into single cells firstly by papain digestion at 37oC for 3 min. 
The digestion was stopped by equal volume of ice-cold Ovomucoid solution. Then the tissue 
was dissociated into single cells by pipetting 10 time with 1 ml tip and then 20 times with 200 µl 
tip in 400 µl sort medium. The cells were filtered through a 35 µm cell strainer cap of BD 
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Falcon tube. The dissociated cells can be used for neurosphere culture in E/F medium or 
stained for sorting. 
2.2.3.2 Cell staining and FACS  
The cells were stained both with Prominin-PE (1:100) and EGF-Alexa 647(1:1000) to get a 
four-population sort. The gates of different populations were set according to the controls list 
below: 
Autofluorescence  Without any staining (For FSC or SSC 
setting) 
Autofluorescence+ PI (Propidium iodide)  Stained only with PI (For PI gate setting) 
Prominin Positive Control Stained only with Prominin-PE (For 
Prominin positive gate setting) 
Block Control The cells were blocked with EGF before 
staining with EGF-Alexa647 (For EGFlow 
gate and EGFhigh gate setting) 
EGF Positive Control Stained only with EGF-Alexa647 (to 
confirm the EGFhigh gate setting) 
The cells were sorted into 1.5 ml or 0.5 ml Eppendorf tubes after finishing the gate setting at a 
threshold of 300-500 events per second. For clonal analysis, the cells were sorted directly into 
a 96-well plate, which was pre-filled with warm medium.  
2.2.4 RNA extraction and Taqman gene expression assay 
2.2.4.1. RNA Extraction and retro-transcription into cDNA 
The cells were sorted directly into RNA lysis buffer with a ratio of 10 µl per 1000 cells. And the 
cells were homogenized by brief vortexing for 30 s after sorting. RNA was extracted according 
to the protocol recommended by the manufacturer. Briefly, the lysate was mixed with one 
volume 70% ethanol before transferring into the spin column. Spin down to discard the 
flow-through. Wash the column with 700 µl RW1, 500 µl RPE and 500 µl 70% ethanol 
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respectively. The RNA was eluted with 14 µl RNase-free ddH2O after discarding the residual 
washing buffer with a full speed of centrifuge. The RNA was retro-transcribed into cDNA 
directly after the extraction. 10 µl RNA was annealed with 2 µl OligodT(15) at 80oC for 3 min. 
And the mixture was transcribed into cDNA with following protocol. 
Total  30 µl 
RNA  12 µl 
5X M-MLV buffer 6 µl 
dNTPs (10 mM) 1.5 µl 
DTT (100 mM) 3 µl 
M-MLV Reverse Transcriptase 2 µl 
RNasin (40 U/µl) 0.7 µl 
RNase-free ddH2O 4.8 µl 
All the reagents were mixed well and incubated at 42oC for 60 min and then the reverse 
transcription was stopped by incubation at 80oC for 10 min. The cDNA was diluted in 90 µl 
RNase-free ddH2O and stored at -20oC before qPCR. 
2.2.4.2. Taqman gene expression assay 
To analyze the mRNA expression of different populations of both WT and Tlx-/-, the Taqman 
gene expression assay was used. The analysis was based on the pre-designed probes for the 
interested genes. And beta-actin was chosen as reference gene.  
Taqman Assay Mixture 20 µl total 
Taqman Master Mix (2X) 10 µl 
Probe 1 µl 
RNase-free ddH2O 4.5 µl 
cDNA 4.5 µl 
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The mixture was denatured at 95oC for 10 min and followed by 50 cycles of 95oC denature for 
15 s and annealing at 60oC for 1 min. And the data was collected during the annealing 
procedure.  
2.2.5 Luciferase assay and chromatin immunoprecipitation assay (ChIP) 
2.2.5.1. Luciferase assay 
1. Luciferase assay with HEK293FT cells 
Around 3-4X104 cells each well of 96-well plate were seeded 24 h before transfection. The 
plasmids were prepared as listed below (with or without NICD) in 75 µl Opti-MEM for triplicate 
wells. 9 µl peqFECT DNA transfection reagent was added and mixed well. The mixture was 
incubated at RT for 20 min before aliquoting to three wells. The luminescence was measured 
48 h after transfection according to the protocol of manufacturer. Briefly, 75 µl of Dual-Glo 
reagent was added into each well to lysate cells. The firefly luminescence was measured 10 
min later in a luminometer. And then 75 µl Dual-Glo Stop & Glo reagent was added to quench 
the firefly luminescence and trigger the Renila luminescence. The Renila luminescence was 
measured 10 min later. The ratio of firefly to Renila luminescence was calculated for each well 
and then normalized the ratio to control (FUGW). All the experiments were done in triplicate 
and the samples were transferred into a 96 well plate with opaque walls before measuring 
luminescence. 
Without NICD Cotransfection With NICD Cotransfection 
FUGW or FUGW-Tlx       375 ng FUGW or FUGW-Tlx       375 ng 
Luciferase Reporter plasmid 375 ng Luciferase Reporter plasmid 375 ng 
Renila Reporter plasmid    7.5 ng Renila Reporter plasmid    7.5 ng 
 pCAGGS-mNICD1         375 ng 
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2. Luciferase assay in neurosphere cultures 
The SVZ cells were derived from p7 WT pups and dissociated into single cells for neurosphere 
formation in E/F medium at a density of 105 cells/ml. Neurospheres were formed after 5-7 days 
culture in a 37oC humidified incubator with 5% CO2. The neurospheres were dissociated into 
single cells after incubating with Accutase for 5 min at 37oC. The single cells were either 
expanded or transfected. 5X105 single cells were transfected by 4D-Nucleofector with a 16 
well nucleocuvette. The cells were spun down to remove medium and cells pellet was 
resuspended by 20 µl P3 primary cell solution contained the plasmids listed below. The cells 
were transferred into one well of the cuvette and pulsed with DS113 program and then 
respuspended with 180 µl prewarmed E/F medium for each well. The transfected cells from 
one nucleocuvette well were transferred into one well of 6-well plate for further culture of 48 h. 
The cells were collected and aliquoted into two wells of a 96 well plate with opaque walls to 
measure the luciferase assay. And the protocol is same as HEK cells shown above. 
FUGW or FUGW-Tlx       2.5 µg 
Luciferase Reporter plasmid 2.5 µg 
Renila Reporter plasmid    50 ng 
pCAGGS-mNICD1         2.5 µg 
2.2.5.2 Chromatin immunoprecipitation assay (ChIP) 
The neurospheres derived from adult WT SVZ were used for ChIP. The culture and the 
expansion of the neuroshperes were same as the neurospheres derived from p7 mice. 1X106 
single cells were used for transfection. 5 µg FUGW-Tlx along with 4 µg pCAGGS-NICD1 were 
transfected into cells by 4D Nucleofector. The cells were cultured in E/F medium for 48 h 
before fixed with formaldehyde. The protocol was modified from Magna ChiP A Kit (Millipore). 
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1. Reagents for the ChIP 
Cell lysis buffer  
Hepes pH 7.9 10 mM 
MgCl2 1.5 mM 
KCl 10 mM 
Igepal 0.5% 
Nuclear lysis buffer  
SDS 1% 
EDTA 10 mM 
Tris-HCl pH8.1 50 mM 
Dilution buffer  
SDS 0.01% 
Triton-X100 1.1% 
EDTA 1.2 mM 
Tris-HCl pH8.1 16.7 mM 
NaCl 167 mM 
Low salt wash buffer  
SDS 0.1% 
Triton-X100 1% 
EDTA 2 mM 
Tris-HCl pH8.1 20 mM 
NaCl 150 mM 
High salt wash buffer  
SDS 0.1% 
Triton-X100 1% 
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EDTA 2 mM 
Tris-HCl pH8.1 20 mM 
NaCl 500 mM 
LiCl wash buffer  
LiCl 0.25 M 
Igepal 1% 
SOD 1% 
EDTA 1 mM 
Tris-HCl pH8.1 10 mM 
TE buffer  
Tris-HCl pH8.1 10 mM 
EDTA 1 mM 
ChIP elution buffer  
SDS 1% 
NaHCO3 50 mM 
Tris-HCl pH8.1 50 mM 
EDTA 1 mM 
Proteinase K (add before use) 50 ng/µl 
2. Primers for qPCR 
Hes1 promoter specific primers 
Sense    5’ CTGGGCTTTGCTTAGTTT 3’ 
Antisense 5’ TTTACCTTGTTCCCTCCT 3’ 
 
Hes5 promoter specific primers 
Sense   5’GCACGCTAAATTGCCTGTGA 3’ 
Antisense 5’ CCCGGGATGCTAATGAGGAC3’ 
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3. Crosslinking and lysis of the cells 
The protein and DNA were crosslinked by adding 230 µl 37% formaldehyde (final 
concentration 1%) into 10 ml medium at RT for 10 min. The crosslink was stopped by adding 1 
ml 1.25 M Glycine and incubating at RT for 5 min. The cells were collected by centrifuge at 800 
g for 5 min at 4oC. And the cell pellet was washed twice with 2 ml ice-cold PBS containing 20ul 
Protease Inhibitor Cocktail II (PIC) (Roche, 25X solution). The cell pellet was resuspended in 
500 µl Cell Lysis buffer containing 5 µl PIC. The cell suspension was incubated on ice for 15 
min and then vortexed every 5 min. Centrifuge to collect the pellet and resuspended in 200 µl 
Nuclear Lysis buffer containing 2 µl PIC. The DNA of cell suspension was sheared into 
200-1000 bp in length by sonicating for 5 min with 30 s off in between 30 s pulses in ice water 
slurry bath. The debris was removed by centrifuge 15,000 g for 10 min at 4oC. The supernatant 
was aliquoted into 50 µl and stored at -80oC for up to three months.  
4. Immuniprecipitatioin (IP) of cross-linked protein/DNA complex 
Remove two 50 µl aliquots from -80oC and diluted in 450 µl Dilution buffer (5 µl PIC). Take 1% 
solution as input. And add 5 µl Tlx rabbit IgG or 2 µl normal rabbit IgG into each aliquot and 
incubate at 4oC for 1 h before adding 20 µl Protein G beads for overnight incubation. The next 
day wash the magnetic beads with 500 µl of each Low Salt Wash Buffer, High Salt Wash 
Buffer, LiCl Wash Buffer and TE Buffer for 3-5 min in 4oC cold room, sequentially.  
5. Elute the protein/DNA complex and free the DNA 
The protein/DNA complex was eluted from the beads by incubating them with 100 µl Elution 
buffer which contains 1 µl proteinase K at 62oC for 1 h on a shaking plate. Both the inputs and 
samples were treated with proteinase K. The proteinase K was inactivated at 95oC for 10 min. 
The DNA was purified with Qiaquick PCR Purification Kit and resolved in 50 µl ddH2O. 
6. qPCR to analyze the enrichment of protein/DNA complex 
Take 2 µl of either input or sample to the master mixture list below and analyze the enrichment 
by qPCR. The samples were denatured at 95oC for 10 min and followed by 43 cycles of 10 s 
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95oC denature and 1 min 58oC annealing. The data was collected at annealing procedure. All 
the experiments were done in triplicate. The signal of the sample was calculated as 2-(Ct sample- 
Ct input). The fold enrichment is expressed as the ratio of Tlx rabbit IgG signal to Normal rabbit 
IgG signal. 
Total 18 µl 
SYBR-Green Master Mix (2X) 10 µl 
ddH2O 7 µl 
Primer mix (20 µM) 1 µl 
2.2.6 Stereotactic injection and slicing 
The mice were fixed in a stereotactic frame after the sedation with sleeping mix. The bregma 
was used to locate the ventricle. 1 µl DMSO or 10 mM DAPT was injected into the ventricle 
with the coordinates of AP 0 mm, ML 1 mm, DV 2 mm for WT and AP 0.5 mm, ML 0.5 mm, DV 
2 mm for Tlx-/- mice. When the virus was injected, the coordinates of AP 1.2 mm, ML 0.5 mm 
and DV 2.5 mm were used for both WT and Tlx-/- mice. The liquid was applied with a 
pump-driven nanofil syringe (10µl) at a speed of 200 nl/min. The needle of the syringe was 
pulled out slowly 5 min after the completion of the injection. The mice were woken up with 
waking up mix along with painkiller after the skin was stitched up. The mice were placed on the 
38-40oC heating plate during the surgery and the cages were kept on heating plate 24-48 h 
more to let the mice to recover. 
Sleeping Mix 7 ml total 
0.9% NaCl  4.5 ml 
Dormitor (1 mg/ml Medetomedin) 0.5 ml 
Dormicum (5 mg/ml Midazolam) 1 ml 
Fentanyl (0.05 mg/ml) 1 ml 
  
Materials and methods 
	   36 
Waking Mix 8.5 ml total 
Antisedan (5 mg/ml atipamezol) 0.5 ml 
Anexate (0.1 mg/ml Flumazenil) 5 ml 
Naloxon (0.4 mg/ml Naloxon) 3 ml 
  
Painkiller 5 ml total 
0.9% NaCl 4.75 ml 
Temgesic (0.324 mg/ml Buprenorphin) 0.25 ml 
2.2.7 Immunohistochemistry and immunocytochemistry 
2.2.7.1 Immunohistochemistry 
The mice brains were perfused with 10% formalin after i.p. injection of 50 µl 
sodium-pentobarbital (Narcoren, Merial, 400 mg/kg body weight). The brains were removed 
and fixed in 10% formalin 4oC overnight. After washes with 0.1 M PBS, brains were embedded 
in 4% low melt agarose. Coronal sections were cut at a thickness of 40 µm with Vibratom and 
then processed for immunohistochemistry. The slices were permeabilized by NP40 for 30 min 
and the residual formalin was quenched by 0.1 M glycine/ 0.1 M PBS and 50 mM NH4Cl/0.1M 
PBS for 30 min sequentially. And primary antibody was applied overnight at 4oC after 
immersing the slices in 5% FCS/0.1 M PBS for 1 h at RT. The secondary antibody was applied 
for 1 h at RT after washing the slices three times with 0.1 M PBS. All the antibodies were 
diluted in 5% FCS/0.1M PBS. DAPI was used for nuclear counterstaining for 1 min at RT. The 
slices were mounted onto the glass slides with Mowiol after washing with ddH2O and drying 
with filter paper. The Mowiol was dried at RT for 1-2 h and the slices were stored at 4oC until 
taking image. 
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2.2.7.2 Immunocytochemistry 
The sorted cells were incubated for extra 4 h in F medium to attach to the matrigel pre-coated 
chamber slide. Cells were fixed in 3% paraformaldehyde in PBS that contains 4% sucrose for 
10-15 min, then rinsed twice with 10 mM glycine/0.1 M PBS. The cells were either stored at 
4°C in 10 mM glycine/0.1M PBS or permeabilized in 0.5% NP-40/0.1 M PBS for 5 min. The 
primary antibodies were applied overnight at 4°C after rinsing the cells with 0.1 M PBS twice. 
The next day, the secondary antibody was applied to the cells for 1 h at RT after washing the 
cells three times with 0.1 M PBS. The cell nuclei were stained with DAPI. Around 5-10 µl of 
Mowiol was placed on each well of the chamber-slide and a 24 mm X 60 mm glass coverslip 
was gently placed on top of it. And air bubble should be avoided. 
2.2.7.3 Confocal microscopy 
All the images were acquired using a laser scanning confocal microscope (Leica TCS SP2). 
Three slices each mice were used for immunohistochemistry and imaging.  
2.2.8 Statistics 
All the imaging data were analyzed with LCS lite (Leica Confocal Software) and Image J. 
Statistic analysis was performed with two-tailed homoscedastic Student’s T test or paired T 
test by SigmaStat (n.s.: not significant; *: p < 0.05; **: p < 0.01; ***: p < 0.001). Graphs were 
made with Microsoft Excel 2007 and Adobe illustrator CS4. 
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3. Results 
3.1 Neurogenesis is impaired in Tlx-/- mice 
3.1.1 Comparative analysis of the various precursor types in the WT and Tlx-/- SVZ  
Neural stem cells (NSCs) in the adult mammalian brain continue to generate new neurons 
throughout the life span of the animal. Adult NSCs are relatively quiescent and undergo cell 
division only upon cell cycle entry. An essential regulator for promoting cell cycle entry of adult 
NSCs is the nuclear orphan receptor Tailless (Tlx) and mice lacking Tlx display reduced 
hippocampal dentate gyri, greatly expanded lateral ventricles and reduced olfactory bulbs, 
indicating a greatly impaired neurogenesis (Monaghan et al. 1997). 
To investigate the molecular mechanisms underlying the impairment of neurogenesis in Tlx-/- 
mice, our group has developed a fluorescence activated cell sorting (FACS) based approach.  
By measuring the levels of Prominin-1 (P) and EGFR (E) expression at the surface of 
dissociated SVZ cells we were able to separate quiescent NSCs (qNSCs) in the P+E- 
population and activated NSCs (aNSCs) and their immediate progeny transit-amplifying 
precursors (TAPs) in the P+E+ and P-E+ subsets, respectively. We also found that the last 
population of P-E- cells represents mostly neuroblasts if the cells are isolated from the 
neonatal SVZ (Carrillo-Garcia et al., 2010; Cesetti et al., 2009). Instead when cells are isolated 
from the adult SVZ, this population includes a large fraction of niche astrocytes (Khatri et al., 
2014). To establish correct gate setting I used various controls, including, an autofluorescence 
control was used to obtain the intact cell gate (P2 gate) to exclude cell debris and doublets 
(Figure 3.1 A). And the cells stained only with propidium iodide (PI) were used to set the viable 
cell gate (P3 gate) to exclude the dead cells during the sample preparation procedure (Figure 
3.1 B). These controls were used also to establish the negative gate for Prominin-1 staining 
(Figure 3.1 D). In contrast, to determine EGFR expression I used an Alexa647-conjugated 
EGF (Ciccolini et al., 2005). Negative gates in this case were set based using cells pretreated 
with EGF before staining with EGF-Alexa647, to control for unspecific binding of 
EGF-Alexa647 on the cell surface (Figure 3.1 C). On average, the Prominin-1 immunopositive 
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cells represented were set based on WT control with an average yield of 1-2% of all cells 
which were selected as Prominin-1 positive (P+) (Figure 3.1 F) while the EGFR gate sorted 
only 1.5-2.5% EGFRhigh cells (E+) (Figure 3.1 E). The P+E-, P+E+, P-E+ and P-E- cells were 
sorted according to the intersectional gate settings of Prominin-PE and EGF-Alexa 647. 
Representative plots of these four populations in both WT (Figure 3.1 E, F, G, H) and KO (Tlx-/-) 
(Figure 3.1 I, J, K, L) are shown below, respectively. 
 
Figure 3.1 Representative gate settings of fluorescence activated cell sorting (FACS). The dissociated cells of 
the SVZ (P7) were stained with both Prominin-1-PE and EGF-Alexa647. The intact cell gate (P2) was set according to 
the autofluorescence control (A) as well as the viable cells gate (P3) was set by PI only staining (B). Meanwhile the 
EGFR (E- and E+) gates were set according to the control pre-blocked by EGF before EGF-Alexa647 single staining 
(C). The Prominin-1 negative gate (P-) was set based on a control with only PI staining (D) while the Prominin-1 
positive gate (P+) based on both Prominin-1 and PI staining (F). The P+E-, P+E+, P-E+ and P-E- cells were sorted 
according to the intersectional gate settings of PE and Alexa647. Representative plots of these four populations in 
both WT (E, F, G, H) and KO (Tlx-/-) (I, J, K, L) are shown. 
By comparing the percentage of the four populations in WT and Tlx-/- neonatal mice (postnatal 
day 7, p7), I found that in the latter a higher percentage of P+E- cells, which consist of qNSCs 
and ependymal cells, and a concomitant decrease in the number of aNSCs (P+E+) and TAPs 
(P-E+) (Figure 3.2 A). These changes were not due to differences in cell viability among the 
Results 
	   40 
genotypes as, the percentage of dead cells between WT and Tlx-/- mice analysed, as indicated 
by PI staining, revealed no significant differences (Figure 3.2 B). 
 
Figure 3.2 Neurogenesis is impaired in Tlx-/- mice. (A) The percentage of P+E- cells (qNSC) of Tlx-/- mice (P7) was 
increased while the P+E+ cells (aNSC) and P-E+ cells (TAPs) were decreased. (B) The percentage of PI+ cells was 
not significantly different between WT and Tlx-/- mice. (Data are presented as mean ± SEM. and n≥3. * indicate P 
values <0.05) 
Taken together, these data showed that the Tlx-/- mice display a higher number of P+E- cells, 
which include quiescent NSCs with a concomitant depletion of proliferating aNSCs and TAPs. 
Since we have previously shown that NSCs are not depleted in the mutant SVZ (Obernier et 
al., 2011), these data suggest that lack of Tlx leads to an impairment of NSC activation.  
3.1.2 Comparative analysis of MASH1 expression in the WT and Tlx-/- SVZ 
Mash1 is a transcription factor that in the SVZ expressed in aNSCs and especially in 
intermediate progenitors and neuroblasts (Carrillo-Garcia et al., 2010; Khatri et al., 2014). We 
have previously shown that the gene expression of Mash1 is downregulated in mutant aNSCs 
at P7 (Obernier et al., 2011). To confirm the reduction in aNSCs and TAPs in the SVZ of adult 
Tlx-/- mice, we analyzed Mash1 expression at the protein level by using immunohistochemistry. 
The percentage of MASH1+ cells in the SVZ was greatly reduced throughout the mutant SVZ 
including the dorsal and the lateral region of the niche (Figure 3.3 A, B), underscoring the 
impairment of NSC activation and lineage progression in the SVZ of Tlx-/- mice. 
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Figure 3.3 Percentage of MASH1+ cells decreases in Tlx-/- mice. The MASH1+ cells (Green) in both WT and KO 
were counted along the dorsal and lateral ventricle and the percentage of MASH1+ cells was calculated against DAPI 
stained nuclei (blue) of the indicated region by the dashed line. The representative staining is shown on the left (A) 
and the quantitative analysis is shown on the right (B) respectively. (Data are presented as mean ± SEM. and n≥3. *** 
indicate P values <0.001) 
3.2 Gene expression profile of Notch signaling in WT and Tlx-/- mice 
3.2.1 Gene expression profile in P+E-, P+E+, P-E+ and P-E- cells of the SVZ at P7 
Adult neurogenesis is initiated only when qNSCs enter the cell cycle and become aNSCs. 
Therefore, to begin to investigate the mechanisms underlying the inability of mutant NSCs to 
enter the cell cycle, I next analyzed the gene expression profile changes of aNSCs between 
WT and Tlx-/- mice. We found that the Mash1 mRNA was downregulated in aNSCs 
(P+E+)(Figure 3.4 A), which confirmed our previous findings and was consistent with the 
reduction in protein expression observed in adult Tlx-/- mice. More interestingly, we also found 
that Notch signaling effector genes Hes1 and Hes5 were significantly changed in aNSCs 
(P+E+)(Figure 3.4 B and C).  
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Figure 3.4 The gene expression profile of WT and Tlx-/- p7 mice. (A) Mash1 expression is downregulated and (B) 
Hes1 is upregulated in the aNSCs (P+E+) of Tlx-/- mice. (C) Hes5 is downregulated in both qNSCs (P+E-) and aNSCs 
(P+E+). The fold changes of gene expression were normalized to WT P-E- cells (A, B, C) respectively. (Data are 
presented as mean ± SEM. and n≥3. * indicate P value <0.05, ** indicate P value <0.01) 
Previous research showed that Hes1 and Hes5 compensate each other (Ohtsuka et al., 1999). 
Therefore, it is possible that the deregulation of Hes1 (Figure 3.4 B) and Hes5 (Figure 3.4 C) 
expression in opposite direction in aNSCs maybe an attempt to compensate an upregulation 
of Notch Signaling in the Tlx-/- niche. Intriguingly, Hes5 is downregulated also in the qNSCs 
(P+E-), which implied that the Notch signaling is already altered in this cell population.  
3.2.2 Comparative analysis of NICD1 positive cells in P+E- and P-E- of adult SVZ 
Since the expression of Notch signaling molecules is upregulated in the SVZ of Tlx-/- mice, I 
next investigated whether the activated form of Notch1, NICD1 (Notch1 intercellular domain) is 
also upregulated in the adult SEZ. Therefore, after staining for Prominin-1 and EGFR and 
sorting the four populations from the adult SVZ, cells were plated on coverslips and stained 
with NICD1 antibody. Since EGFRhigh cells are very few in Tlx-/- adult mice, aNSCs and TAPs 
could not be analyzed. And these experiments were performed only to compare P+E- and 
P-E- cells. Two different patterns of NICD1 immunostaining were detected. In some cells the 
immunoreactivity colocalized with the DAPI counterstaining of the nuclei, indicating a late 
stage of activated Notch signaling, where NICD1 is already translocated into the nucleus 
(Figure 3.5 A). In contrast, in its early activated, poised NICD1 is located close at the 
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membrane of the nucleus (Figure 3.5 B) (Andersson et al., 2011). Quantification of the 
immunostainings revealed that (Figure 3.5 C), independent of the genotype, around 30% of 
P+E- cells displayed either nuclear or perinuclear NICD1 immunoreactivity (NICD1+) and only 
40% were NICD1-, underscoring the importance of Notch signaling in the regulation of NSC 
quiescence. The absence of a significant difference in the distribution of NICD1 between WT 
and Tlx-/- P+E- cells was surprising (Figure 3.5 D), but it could be a consequence of the 
involvement of other Notch receptors, which could not be detected by the antibodies used here. 
However, I found that the percentage of nuclearized NICD1 in the population of Tlx-/- P-E- cells 
was significantly higher than in the WT counterpart (Figure 3.5 E). As it was reported that the 
P-E- population includes a minor subset of NSCs (Codega et al., 2014; Walker et al, 2013), 
this results suggest an upregulation of Notch1 signaling in this population of NSCs. 
 
Figure 3.5 Comparative analysis of NICD1 staining in the adult SVZ in P+E- and P-E- populations. 
Representative pictures of NICD1 staining of sorted cells show that activated Notch1 in the nuclear (A), nuclear 
membrane (B) or negative (C). The percentage of NICD1+ cells in WT and Tlx-/- (D, E) are shown at right. (Data are 
presented as mean ± SEM. and n≥3. * indicate P values <0.05; ** indicate P values <0.01) 
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3.2.3 Comparative analysis of gene expression in NSCs derived from the dorsal and 
lateral SVZ  
As illustrated above (Figure 3.3 A), most of the MASH1+ cells were located at the corner 
formed by the junction between the dorsal and the lateral part of the germinal niche, indicating 
more active neurogenesis in this region. NSCs in dorsal and lateral regions of the ventricles 
have a distinct differentiation potential (Young et al., 2007), indicating that they represent two 
pools of functionally distinct NSCs. Therefore, I next used differential dissection to separate 
the dorsal and lateral pools of NSCs in the WT (Figure 3.6 A) and Tlx-/- (Figure 3.6 A’) SVZ. 
 
Figure 3.6 Comparative analysis of NSCs compositions in dorsal and lateral regions of SVZ. The scheme (A, 
A’) shows the defined regions of SVZ in WT and Tlx-/-, respectively. In the Tlx-/- mice the percentage of qNSCs 
increased while the aNSCs and TAPs decreased in both dorsal (B) and lateral (C) regions. (Data are presented as 
mean ± SEM. and n≥3. * indicate P values <0.05; ** indicate P values <0.01; *** indicate P values <0.001) 
Consistent with the previous analysis of the total SVZ, I found an enrichment of qNSCs (P+E-) 
with a concomitant depletion of aNSCs (P+E+) and TAPs (P-E+) in both dorsal and lateral 
regions of the Tlx-/- niche, indicating that the effect of Tlx on NSCs quiescence is not affected 
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by regional cues (Figure 3.6 B and C). 
To investigate whether the Notch signaling is involved in regulating the NSC maintenance in 
Tlx-/- mice, I analyzed the expression profile of genes involved in Notch signaling in qNSCs 
(P+E-) sorted from the dorsal and lateral ventricle of neonatal WT and Tlx-/- mice (P7) (Figure 
3.7).  
 
Figure 3.7 Notch signaling upregulated in qNSC (P+E-) of Tlx-/- niche. The gene expression profile of Notch 
signaling genes Hes1 (A), Hes5 (B), Mash1 (C), Dll1 (D), Notch1 (E), Notch3 (F) and RBPJ (G) in both dorsal and 
lateral region. (Data are presented as mean ± SEM. and n≥3. * indicate P value <0.05) 
I found that compared to the WT counterparts Notch3 but not Notch1 was significantly 
upregulated in Tlx-/- qNSCs (Figure 3.7 E and F). The Notch effector gene Hes1 was also 
upregulated in both dorsal and lateral qNSCs (Figure 3.7 A), which was previously failed to 
distinguish by combining the dorsal and lateral qNSCs together. In contrast, the RBPJ and 
Mash1 were upregulated only in the dorsal region of niche (Figure 3.7 G and C), indicating a 
different gene expression profile between regionally distinct qNSCs. RBPJ is a molecular 
switch, which could initiate the expression of Hes1 upon NICD binding (Ables et al., 2011). 
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This suggests that the NICD-RBPJ signaling cascade underlies the activation of Hes1 in the 
dorsal region. Nevertheless, in the lateral region, it is still unclear how NICD-RBPJ signaling is 
involved in upregualting the Hes1 expression. Surprisingly, the Mash1 was also upregulated in 
the dorsal Tlx-/- qNSCs (Figure 3.7 C) although the overall expression level was very low 
compared to those observed in TAPs (Figure 3.4 A). This may imply that in qNSCs the Mash1 
upregulation was favored by the Tlx mutation. Finally, there was no significant difference in the 
expression of Notch1, Dll1 and Hes5 in qNSCs (P+E-) between WT and Tlx-/- mice (Figure 3.7 
E, D and B). 
I next performed a similar analysis in the P-E- population of neonatal Tlx-/- mice (Figure 3.8). 
Interestingly, I found that Notch signaling effector gene Hes1 was also upregulated in both 
corner and lateral region of Tlx-/- mice (Figure 3.8 A), which confirmed our finding about NICD1 
staining in adult P-E- cells (Figure 3.5 E). Moreover, in P-E- isolated from the lateral SVZ of 
Tlx-/- mice, transcripts for Hes5 were also upregulated (Figure 3.8 B). Although Notch 
receptors Notch1 and Notch3 were not upregulated in the dorsal region (Figure 3.8 E and F), 
one of the very important ligand for Notch1 the Dll1 gene was significantly upregulated in this 
region of Tlx-/- mice  (Figure 3.8 D). In contrast, the genes Mash1 and RBPJ were not 
significantly different in their expression between WT and Tlx-/- mice (Figure 3.8 C and G). 
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Figure 3.8 Notch signaling is upregulated in P-E- cells of the Tlx-/- niche. Gene expression profile of Notch 
signaling genes Hes1 (A), Hes5 (B), Mash1 (C), Dll1 (D), Notch1 (E), Notch3 (F) and RBPJ (G) in both dorsal and 
lateral region. (Data are presented as mean ± SEM. and n≥3. * indicate P values <0.05; ** indicate P values <0.01)  
3.3 In Vivo modulation of Notch signaling by DAPT 
3.3.1 The proliferation of NSCs in SVZ increases after DAPT treatment 
I found that the Tlx-/- mice have upregulated Notch signaling and impaired neurogenesis. Since 
Notch signaling has been shown to promote cell quiescence in the adult SVZ (Chapouton et al., 
2010), the increase in qNSCs maybe a consequence of increased Notch signaling. Therefore, 
I reasoned that the impaired neurogenesis in Tlx-/- mutants may be rescued by inhibitors of the 
Notch signaling (Figure 3.9 A). To verify this hypothesis in vivo, I injected the Notch Inhibitor 
DAPT (10mM) and the vehicle control DMSO into the right and left ventricles respectively of 
adult WT and Tlx-/- mice. After 24 hours the mice were sacrificed and brain slices were 
immunostained with Ki67 antibodies to analyze the effect of the injection on the number of 
cycling cells. The percentage of Ki67 positive (Ki67+) cells was significantly increased in the 
dorsal region of DAPT treated ventricle in both WT and Tlx-/- mice (Figure 3.9 B and C), 
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showing that that qNSC could re-enter the cell cycle upon inhibition of Notch signaling. 
 
Figure 3.9 Proliferation of NSCs in SVZ increases after DAPT treatment. The Ki67+ cells (Green) in both WT and 
Tlx-/- were counted along the dorsal line of ventricle and the percentage of Ki67+ cells was calculated against DAPI 
stained nuclei (blue) of the indicated region by the dashed line. Representative staining is shown (A) and the 
calculation (B, C), respectively. (Data are presented as mean ± SEM. and n≥3. ** indicates P values <0.01; *** indicate 
P values <0.001) 
3.3.2 Identification of the cell types affected by DAPT treatment 
To find out which precursor type is affected by the blockade of Notch signaling, I injected mice 
intraventricularly with DMSO and DAPT as illustrated above (Figure 3.9 A). After 24 hours 
mice were sacrificed and processed for FACS sorting to isolate the four cell populations. 
Surprisingly, I found that the treatment led to an increase in the percentage of P+E- cells 
(qNSCs) in both WT and Tlx-/- SVZ. In contrast, the percentage of aNSCs was only increased 
in WT mice (Figure 3.10 A and B). Moreover, Tlx-/- mice displayed a small but significant 
decrease in the number of P-E- cells after exposure to DAPT. To identify which cell types 
upregulate Ki67 expression, after sorting cells were plated and processed for Ki67 
immunostaining (Figure 3.10 C and D). This analysis revealed that the treatment induced no 
change in the percentage of Ki67+ cells in the various cell population isolated from WT mice 
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(Figure 3.10 C). Taken together, the data of the FACS analysis show that the increase in the 
number of Ki67+ cells observed in situ in the WT SVZ is a consequence of the increase in the 
total number of P+E- and P+E+ cells displaying Ki67 immunoreactivity. In the mutant SVZ the 
percentage of Ki67+ cells also did not vary among the various populations with the exception 
of the P-E- cells, which displayed a small but significant increase in the percentage of Ki67+ 
cells (Figure 3.10 D). These data suggest that the increase in the number of Ki67+ cells 
observed in Tlx-/- slices is a consequence of the increase in the total number of P+E- cells and 
P-E- cells displaying Ki67 immunoreactivity. They also show that in vivo blockade of Notch 
signaling is not sufficient to rescue the transition of mutant P+E- qNSCs to P+E+ aNSCs. 
 
Figure 3.10 Comparative analysis of populations in the adult SVZ after DAPT treatment.	   The percentage of 
qNSC and aNSC was increased in the DAPT injected ventricle of WT (A).	  The percentage of qNSC was increased and 
P-E- cells were decreased in the DAPT injected ventricle of Tlx-/- mice (B).	   The percentage of Ki67+ cells did not 
change after DAPT injection (C, D) but in the P-E- population of Tlx-/- mice (D). (Data are presented as mean ± SEM. 
and n≥3. * indicate P values <0.05; ** indicate P values <0.01; *** indicate P values <0.001) 
3.3.3 Inhibition of Notch signaling promotes P-E- cells to be P+  
My previous analysis shows that in both WT and in mutant mice the total number of P+E- cells 
almost doubles 24 hours after DAPT treatment without a concomitant increase in the 
proportion of Ki67+ cells. This suggests that some of the P-E- cells may become P+E- cells 
upon Notch inhibition. This hypothesis is consistent with previous findings (Wang et al., 2008). 
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It is also consistent with my observations that a subset of mutant P-E- cells display over 
activation of Notch signaling (Figure 3.5 E), that in the Tlx mutant SVZ the percentage of P-E- 
cells which are cycling increases whereas the total number P-E- cells decreases upon DAPT 
treatment. 
To further investigate this hypothesis, I sorted the P-E- cells of adult WT and Tlx-/- mice by 
FACS. Thereafter the cells were cultured in the presence of either vehicle (DMSO), 20 µM or 
40 µM DAPT in FGF2 containing medium for one day in vitro. Then, the cells were stained with 
Prominin-1 for analysis (Figure 3.11).  
 
Figure 3.11 Inhibition of Notch signaling promotes P-E- cells to become P+ cells. The P-E- cells sorted from 
both WT and Tlx-/- adult mice were cultured for 1 day before FACS analysis of Prominin-1 staining. The percentage of 
P+ cells was significant increased in the presence of 40 µM DAPT in both WT (A) and Tlx-/- (B). (Data are presented as 
mean ± SEM. and n≥3. * indicate P values <0.05) 
The percentage of P+ cells was increased when the cells were cultured in presence of 40 µM 
DAPT in both WT and especially Tlx-/- cultures (Figure 3.11 A, B). These data suggest that 
there is a subset of cells in the P-E- population, which may re-establish the expression of stem 
cell marker Prominin-1 when Notch signaling is blocked. 
3.4 TLX represses Notch effector gene Hes1 and Hes5 
3.4.1 TLX represses transcription of Hes1 and Hes5 
To analyze how TLX regulates expression of Hes1 and Hes5, I took advantage of a luciferase 
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assay. To this end, I used plasmids that the promoters of Hes1 and Hes5 were cloned 
upstream of the Luciferase reporter gene respectively (Figure 3.12 A) (Nishimura et al., 1998) 
and co-transfected constructs with either an empty plasmid (FUGW) as control or a plasmid 
driving TLX (Tlx) expression. Quantitative analysis revealed that overexpression of TLX 
repressed the activity of both Hes1 and Hes5 promoters (Figure 3.12 B). This inhibitory effect 
of TLX was not observed if the RBPJ binding site of the Hes1 promoter was deleted, indicating 
that the repressive effect of TLX on Hes1 transcription is dependent on this sequence which is 
very important for Notch signaling. Co-transfection of a plasmid overexpressing the activated 
form of Notch1 (NICD1, Dang et al., 2006) led to two folds increase of Hes1 promoter and 
twelve folds increase of Hes5 promoter reporter activity, respectively (Figure 3.12 D). Even in 
the presence of NICD1 overexpression, Hes1 and Hes5 were still both repressed in the 
presence of the Tlx coding plasmid. The removal of the RBPJ site from Hes1 promoter 
revealed a slightly activation after cotransfection of NICD1, which suggests that the RBPJ site 
is important for the interaction of TLX on the Hes1 promoter (Figure 3.12 D). To verify the 
interaction of TLX at the RBPJ binding site, an artificial promoter which contains ten copies of 
RBPJ binding sites along with an adTATA mini promoter was cloned upstream of Luciferase 
reporter gene (Mckenzie et al., 2006). There was eight folds increase of the reporter activity 
when Tlx was overexpressed instead of the empty plasmid FUGW (Figure 3.12 C). As control 
we used a plasmid containing only adTATA mini promoter. Surprisingly, there was also three 
folds increase when only adTATA mini promoter was used, hinting the possibility of more 
complex protein-interactions of TLX with transcriptional coregulators. The luciferase activity of 
the plasmid 10XRBPJ-adTATA was greatly increased when NICD1 was cotransfected, which 
showed as expected that the RBPJ sites have a strong interaction with NICD1-RBPJ complex. 
However, the interaction between TLX and RBPJ sites were masked by highly activated Notch 
signaling with overexpressing NICD1 as there was no significant repression upon TLX 
overexpression (Figure 3.12 E).  
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Figure 3.12 TLX represses transcription of Hes1 and Hes5. (A) Scheme of the luciferase reporter plasmids. The 
Luciferase activity of Hes1 and Hes5 promoter were decreased by TLX overexpression with (D) or without (B) 
cotransfected NICD1 in HEK293 cells. The luciferase activity of the promoter with 10 repeats of the RBPJ binding site 
was increased by TLX overexpression (C) but decreased when cotransfected with NICD1 (E) in HEK293 cells. The 
repression of TLX on Hes1/5 transcription was confirmed in neurosphere cultures (F). The repression of Hes1/5 
transcription and the interaction to RBPJ sites was TLX dose-dependent (G, H, I). [10% (0.1Tlx), 20% (0.2Tlx), 100% 
(1.0 Tlx) of the amount of FUGW]] (Data are presented as mean ± SEM. and n≥3. * indicate P values <0.05; ** indicate 
P values <0.01; *** indicate P values <0.001) 
The HEK293 cells are derived from human embryonic kidney cells and represents a 
heterologous system, which may introduce experimental artifacts. Therefore, I next performed 
similar experiments in cultivated neurospheres isolated from the SVZ of adult WT mice. 
Confirming the differences between the two experimental setups endogenous Notch signaling 
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was different between the two systems (HEK293 cells and neurosphere cells). However, also 
in neurosheres I was able to confirm the repression of Hes1/5 by TLX in the presence of forced 
Notch activation (NICD1 overexpression) (Figure 3.12 F). Moreover, the repression of Hes1 
and Hes5 promoters by TLX (Figure 3.12 G and H) as well as the interaction of TLX with the 
RBPJ sites (Figure 3.12 I) both increased with the amount of the transfected construct coding 
for TLX, which likely reflected increasing amounts of TLX protein. 
3.4.2 TLX represses Hes1/5 expression by interacting to RBPJ sites at their promoters 
To verify the interaction of TLX with the promoters of Hes1 and Hes5 I performed Chromatin 
Immunoprecipitation (ChIP) assays in cultivated neurospheres. In Figure 3.13 A is shown the 
region flanked by the primers used for amplification of the DNA fragment containing the RBPJ 
sites in both genes. The DNA fragment from the Hes1 and Hes5 promoters were enriched 
when the protein/DNA complex was precipitated by TLX antibody but not unspecific rabbit IgG 
antibody (Figure 3.13 B and C). Both promoters revealed a significant enrichment of TLX at 
the RBPJ site of Hes1 and Hes5, which indicates that the regulation by TLX is dependent on 
either a direct interaction of the orphan nuclear receptor with the RBPJ or with the 
transcriptional complex assembled at this site. 
 
Figure 3.13 TLX represses Hes1/5 expression by binding to RBPJ sites of their promoters. (A) Scheme of the 
primers amplifying region and RBPJ binding site. The fold enrichment of TLX precipitated promoter region of interest 
in Hes1 (B) and Hes5 (C) compared to unspecific rb IgG (normal rabbit IgG) are shown. (Data are presented as mean 
± SEM. and n≥3. * indicate P value <0.05) 
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3.5 Knocking down Hes1 cannot rescue the quiescence of P+E- cells 
My results have shown that TLX represses the expression of Hes1 in neural precursors and 
that Hes1 expression is upregualted in both mutant P+E- and P+E- cells. Moreover, my data 
suggest that blocking Notch signaling in vivo promotes the proliferation of P-E- precursors and 
their transition to P+E- cells. However, blockade of Notch signalling per se was not enough to 
rescue the transition of P+E- qNSCs to P+E+ aNSCs. Therefore, I next investigated whether a 
decrease in Hes1 expression may rescue the impairment in the proliferation of neural 
precursors. To test this hypothesis, I took advantage of clonal assays to determine the effect of 
Hes1 expression levels on the clone forming ability of either precursor group. After sorting 
P+E- and P-E- cells were infected with AAV either carrying a scramble shRNA or Hes1 shRNA 
after sorted from SVZ of adult mice. The cells were cultivated in the presence of EGF and 
hFGF2 for four weeks and clone formation was checked every week. I found that the treatment 
did not significantly affect the clone formation ability of P+E- cells, which independently of the 
genotype and the transduction regime did not form big clones, indicating that the quiescence 
could not be rescued by merely knocking down Hes1 in this cell population. Downregulation of 
Hes expression also did not affect significanty clone formation of WT P-E- cells (Figure 3.14 A). 
However, around 0.004% cells formed clones in the Tlx mutant P-E- cells upon transduction 
with Hes1 shRNA, showing that increased Hes1 following Tlx deletion promotes quiescence in 
this cell population (Figure 3.14 B).  
 
Figure 3.14 Clonal analysis of P-E- cells infected with AAV. The P-E- cells were infected with AAV either carrying 
a scramble shRNA or Hes1 shRNA immediately after sorting. The clones were counted 1-2 weeks after infection in 
both WT (A) and Tlx-/- (B). (Data are presented as mean ± SEM. and n≥3.
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4. Discussion 
4.1 Neurogenesis is impaired in Tlx-/- mice 
Previous observations have already shown that Tlx-/- mice have greatly expanded lateral 
ventricles, severely reduced hippocampal dentate gyri and reduced olfactory bulbs (Monaghan 
et al. 1997), indicating an impairment of adult neurogenesis. To investigate the cellular 
dynamics underlying the effect of Tlx mutant, our group has previously shown that such an 
impairment of neurogenesis progressively increases from late development into adulthood 
(Obernier et al., 2011). It was also shown that this reflected a progressive decrease in the 
number of E+(EGFRhigh) cells in the mutant SEZ, which include aNSCs and TAPs. This 
ultimately results in the complete absence of E+ cells in the adult mutant SVZ. Finally it was 
found that such a dramatic reduction of E+ cells was due to an arrest of NSCs in quiescent 
status that could be reversed by re-establishment of Tlx expression (Niu et al., 2011).  
Extending these previous observations I here found that aNSCs and TAPs were dramatically 
decreased also in the SVZ of adult Tlx-/- mice. This conclusion was confirmed by quantification 
of MASH1 expressing cells in the WT and mutant SVZ. The proneural gene Mash1 (Ascl1) is a 
bHLH (basic helix-loop-helix) transcription factor highly expressed in EGFR positive SVZ cells 
(Obernier et al., 2011; Khatri et al., 2014). My immunohistochemical analysis revealed not only 
a decreased number of MASH1+ cells in Tlx-/- mice (Figure 3.3 B), but also possible regional 
cues, further affecting the neurogenesis in the mutant SVZ. Whereas the percentage of 
MASH1+ cells were the same in both dorsal and lateral regions of the WT SVZ, almost no 
MASH1+ cells were found in the lateral region of Tlx-/- mice (Figure 3.3 A), which suggested a 
different spatial regulation of NSCs. This was indeed confirmed by the analysis of the different 
populations (P+E-, P+E+, P-E+, P-E-) in these two regions between WT and Tlx-/- mice, 
showing that the number of TAPs was more affected by the lack of Tlx in the lateral than in the 
dorsal SVZ (Figure 3.6 B and C). Consistent with this I also found in situ that the few remaining 
cells displaying MASH1 or Ki67 immunoreactivity were localized at in the dorsal SVZ (Figure 
3.3 and Figure 3.9 respectively). Taken together, these data confirmed a reduction of aNSCs 
in the Tlx-/- mice. Interestingly, it was recently shown that that TLX can activate Mash1 to 
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induce the neuronal lineage commitment of NSCs (Elmi et al., 2010), suggesting that the 
depletion of E+ cells might be a consequence of decreased levels of Mash1 expression 
following Tlx ablation. 
4.2 Notch signaling is upregulated in the absence of TLX  
To further investigate the molecular mechanisms of impaired neurogenesis in Tlx-/- mice, I 
compared the gene expression profile of both WT and Tlx-/- mice (Figure 3.4). Interestingly, I 
found that Notch signaling effector genes Hes1 and Hes5 were both significantly altered in 
aNSCs (P+E+), albeit in opposite directions highlighting a potential compensatory mechanism 
between Hes1 and Hes5 as previously described (Ohtsuka et al., 1999). In these experiments 
values of transcript levels for each population were normalized to the ones of the WT P-E-, 
which was selected as the reference value. This approach allowed me to visualize the 
changes in expression levels of each gene at each stage of lineage progression, and 
highlighted again opposite trends of expression of the two genes in WT precursors. Whereas 
Hes1 is mainly expressed in the population of P+E- cells and it decrease in proliferating 
populations (Figure 3.4 B), Hes5 is mostly expressed in aNSCs (Figure 3.4 C). Nevertheless, 
with this type of analysis I could not detect a change of Hes1 gene expression in the 
population of qNSCs, which was only detected upon direct comparison of WT and Tlx-/- P+E- 
cells.  Although there is no difference of NSC composition in the dorsal and lateral regions of 
SVZ, NSCs from these two regions have different neurogenic fates due to their different 
embryonic origin (Young et al., 2007). For this reason, I compared the gene expression profile 
in qNSCs (P+E-) in these two regions separately (Figure 3.7). Interestingly, the Hes1 was 
upregulated in both the dorsal and lateral portion of the Tlx-/- SVZ. The expression of Hes1 and 
Hes5 in the lateral SVZ was much higher (more than two folds) than in the dorsal region 
(Figure 3.7 A and B). Moreover, independent of the genotype, the Notch ligand Dll1 and Notch 
receptors Notch1 and Notch3 were also expressed at a higher level in lateral than in the dorsal 
SVZ (Figure 3.7 D, E and F). On the other hand, it means that the high level of Notch signaling 
is inversely related to the proliferative capability. Interestingly, the Notch receptor Notch3 but 
not Notch1 was increased significantly in Tlx-/- qNSCs (P+E- cells). Alunni et.al showed that 
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Notch3 signaling is also very important for gating the activation of NSCs (Alunni et al., 2013). 
Moreover, Basak et.al showed that aNSCs but not qNSCs are Notch1-dependent which is 
consistent with our finding (Basak et al., 2012). Interestingly, it was found that in the Notch1–/– 
Drosophila embryo, the expression of Hes5 is reduced while the Hes1 is not (de la Pompa et 
al., 1997). Taken together, my data suggest that the quiescence of NSCs in Tlx-/- mice might 
may be maintained by Notch3 signaling. 
4.3 Notch signaling is upregulated in P-E- cells 
In the canonical Notch pathway, the receptors are cleaved into the Notch extracellular domain 
(NECD) and Notch intracellular domain (NICD) upon binding their cognate ligands on the 
contacting cell. The NICD is then translocated into the nucleus and triggers the expression of 
downstream genes, such as Hes1 and Hes5 (Ables et al., 2011). The balance of NSC 
quiescence and proliferation is regulated by Notch signaling. Its activation causes NSC 
quiescence, whereas its inhibition reinitiates NSC proliferation and subsequent commitment to 
neuronal differentiation (Chapouton et al., 2010). The Notch target gene Hes1 is constitutively 
expressed in brain compartments that have low proliferation rates and it was shown that 
ectopic Hes1 expression reduces proliferation of embryonic neural progenitors in vitro (Baek et 
al., 2006). However, although I observed more qNSCs in the Tlx-/- mouse brain with 
upregulated Hes1 expression, NICD1 nuclear immunoreactivity was not increased in this 
cellular subset (Figure 3.5 D). As the NICD1 antibody can only recognize the activated Notch1 
but not Notch3, this finding may indicate that Notch1 is not the source of elevated Notch 
signaling in Tlx-/- mice qNSCs. This finding needs further investigation by an antibody specific 
for Notch3 intracellular domain. However, the treatment with DAPT in vivo also indicates that 
Notch signaling in the mutant niche may be upregulated only in P-E- but not in P+E- cells 
(Figure 3.10 D). In fact, although blockade of Notch signaling increased proliferation, in both 
genotypes (Figure 3.9), in the WT this reflects increased total numbers of cycling P+E- and 
P+E+ cells (Figure 3.10 A and C), whereas in the Tlx-/- mice only higher numbers of P+E- and 
a higher proportion of proliferating P-E- cells (Figure 3.10 B and D). Together with my 
observation of increased NICD1 immunoreactivity within the population of Tlx-/- P-E- cells 
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(Figure 3.5 E), this suggests the presence of a subset of NSCs included in the P-E- population, 
which do not express Prominin-1 in the presence of high levels of Notch signalling (Codega 
et.al 2014, Neuron). Although most of the P-E- cells are neuroblasts, 1.3% of the SVZ cells 
were clonogenic in neonatal brain (Carrillo-Garcia et al., 2010), which indicated that they are 
NSCs but Prominin-1 negative. By comparing the gene profile of Notch signaling genes of 
P-E- cells in Tlx-/- with WT, I found that lack of TLX led to an increase of Hes1 expression 
levels also in this population (Figure 3.8 A). In fact, this analysis also revealed that the 
mutation in this subset led also to an increase of Hes5 expression (Figure 3.8 B). Although 
there were no significant increase in expression of Notch receptors Notch1 and Notch3 in both 
SVZ regions (Figure 3.8 E and F), the Notch ligand Dll1 was upregulated in the P-E- cells of 
the dorsal mutant SVZ (Figure 3.8 D), which may contribute to upregulate basal Notch 
signaling in these cells. Previous analysis have indicated that Notch signaling represses stem 
cell properties and proliferation in two main cell groups of adult glial cells: multiciliated 
ependymal cells (Carlen et al., 2009) and astrocytes in the brain parenchyma (Magnusson et 
al., 2014). Since no ependymal cells are found in the P-E- cell population (Khatri et al. 2014), it 
is likely that the P-E- cells represent niche astrocytes that like parenchyma astrocytes display 
NSC characteristics upon downregulation of Notch signaling. This interpretation is also 
consistent with the fact that upon DAPT treatment the Ki67 positive cells did not localize in the 
out layer of ventricle suggesting that they are not ependymal cells (Figure 3.9 A). However, 
further experiments aimed at characterizing this population will be necessary to confirm this 
hypothesis. 
Since TLX protein may not be expressed in the DCX positive neuroblast cells (Li et al., 2012), 
which are the main cell types in P-E- cells, and since neuroblasts are less dependent on 
Notch1 receptor signaling (Albes et al., 2010), it is likely that the increase in Hes1 and Hes5 
expression in the mutant P-E- cells occurs in the same subset that displays high levels of 
NICD1 immunoreactivity.  
As mentioned above DAPT injection led to an increase in the total amount of P+E+ only in WT 
but not in Tlx-/- mice. A likely explanation of this observation is that in WT, but not in mutant 
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mice, the increase in the pool of qNSCs leads to a higher number of aNSCs. Thus, TLX 
promotes the transition between qNSCs to aNSCs by an additional mechanism than the 
increase in Notch signaling.  
4.4 TLX represses Notch target genes in a RBPJ binding site dependent 
manner 
The orphan nuclear receptor TLX (NR2E1) has a DNA binding domain recognizing the 
conserved sequence (5’-AAGTCA-3’) (Mangelsdorf and Evans, 1995). TLX functions as 
repressor of Pax2 (Yu et al., 2000), Pten (Zhang et al., 2006) and BMP4 expression (Qin et al 
2014). It was shown in the context of genome regulation that TLX can recruit histone 
deacetylases (HDAC 3 and HDAC5) to the promoters of its target genes, such as p21 and 
Pten (Sun et al., 2007). Here in my thesis, I showed that the Notch target genes Hes1 and 
Hes5 are also repressed by TLX (Figure 3.12). Moreover, chromatin Immunoprecipitation 
(ChIP) assays in neurosphere cultures confirmed that the TLX mediated repression was 
dependent on the RBPJ binding site of the Hes1/5 promoters (Figure 3.13). In classical 
perspective, RBPJ proteins bind constantly at the promoter of Hes genes (Baolo et al., 2002). 
Therefore, the repression of Hes1/5 by TLX may not due to a competitive mechanism with the 
NICD-RBPJ complex at the DNA binding sequence but instead more dependent on 
protein-protein interaction with the complex. However recently, Castel et.al showed that the 
binding of RBPJ to its targets is also inducible and dependents on activation of Notch signaling 
(Castel et al., 2013). 
To investigate the TLX interaction at the RBPJ binding site we used for reporter assays an 
artificial adenoviral TATA mini promoter with 10 copies of RBPJ binding motifs, which 
confirmed that overexpression of TLX indeed activated the transcription of RBPJ consensus 
sequence (Figure 3.12 C and I). This result also highlighted the need of a Hes1/5 promoter 
specific repression sequence or other cofactors for the function of TLX as repressor. In 
addition, cotransfection of NICD1 increased the luciferase activity 6 folds and validated the 
interaction of NICD at RBPJ binding sites (Figure 3.12 E). Interestingly, the control reporter 
plasmid without 10 copies of RBPJ binding motifs was also responsive to TLX but not to NICD 
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overexpression, which suggested that TLX may recruit transcription factors which can interact 
with the TATA box of the mini promoter.  
4.5 P+E- Cells are not clonogenic upon Hes1 knocking down  
The P+E- cells rarely form clones in vitro. Only 3.8% P+E- cells from the neonatal SVZ are 
clonogenic in the presence of EGF and FGF2 (Carrillo-Garcia et al., 2010). And in the adult 
SVZ, the clone-forming cells reduced to 0.1% (Codega et al., 2014; Khatri et al., 2014). I here 
did not observed clone formation from P+E- cells, This is likely due to the very strict sorting 
conditions used here, where only the highly Prominin-1 immunoreactive cells were sorted for 
clonal analysis, which contains more ependymal cells which do not proliferate (Carlen et al. 
2009). Since, it is possible that qNSCs, which display intermediate levels of Prominin-1 
immnuoreactivity were not included in the population sorted for the clonogenic assays, 
whether they can form clones upon Hes1 downregulation needs to be further investigated. The 
behavior of P+E- cells upon knocking down of Hes1 expression needs additionally to be 
investigated in vivo, as the Notch signaling is based on cell-cell contact which is disrupted in 
vitro. However, this analysis is complicated by the difficulty of separately identifying and 
targeting P+E- and P-E- cells in vivo. I found that in the WT adult niche 0.02% cells of the latter 
can form clones while there is nearly no clone-forming cells in Tlx-/- counterpart (Figure 3.14). 
However, downregulation of Hes1 in this population lead to a conspicuous increase in the 
mutant but not in the WT genetic background, showing that lack of TLX promotes quiescence 
in this population by increasing Hes1 expression. Interestingly, the clonogenic cells mildly 
decreased in the WT counterpart when knocking down Hes1. Since the expression level of 
Hes1 is lower in WT than Tlx-/-, this suggests that the quiescence and proliferation are 
regulated in a Hes1-dose dependent manner. However, the assumption still needs to be 
verified.  
4.6 Conclusive model of TLX regulates qNSC activation  
The TLX protein regulates NSC proliferation and differentiation via repression of effector 
genes Hes1 and Hes5, thereby affecting Notch signaling, which has been shown very 
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important for the regulation of NSC behavior in the brain. Indeed, Notch effectors HES1 and 
HES5 can heterodimerize with bHLH factors such as NGN2 and MASH1 to inhibit neuronal 
differentiation (Kageyama et al., 2007). In this study, we proposed a model that TLX represses 
Hes1 and Hes5 expression by interacting with RBPJ binding sites at their promoters thereby 
could release the proneural genes to promote neurogenesis. In the absence of Tlx, the 
increase in Hes1 expression leads to changes in the expression levels of Notch receptors and 
ligands, thereby promoting a progressive accumulation of NSCs in a dormant pool, which 
display high levels of Notch signaling. However, it is still unclear whether upregulation of Hes1 
expression and consequent increase in Notch signaling are also responsible for the 
impairment in the transition from qNSCs to aNSCs observed in the absence of TLX.  
 
Figure 4.1 Schematic overview of the interaction of Tlx and Notch signaling. Tlx competes with the NICD/RBPJ 
complex at RBPJ binding sites of Hes1 and Hes5 promoters. This release the inhibitory effect of Hes1/5 on proneural 
genes Mash1 and Ngn2. (Cartoon adapted from Shimojo et al., 2011 with modification) 
4.7 Therapeutic prospect of TLX and neural stem cells 
Recently, Zhu et.al demonstrated that brain cancer stem cells are TLX positive and showed 
that TLX is an indicator for poor survival prognosis of human glioblastoma patients. Therefore, 
TLX is a promising therapeutic target for the understanding of brain tumor biology (Zhu et al., 
2014). Moreover, Benod et.al showed that small compounds can bind to the human TLX 
Tlx 	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protein and enhance its repressive activity (Benod et al., 2014) underscoring the therapeutic 
potential of the manipulation of TLX function in cancer stem cells.  
Understanding TLX function may have implication also for pathologies other than brain 
tumours. In fact, induced pluripotent stem cells (iPS) provide a renewable source for the 
transplantation therapy of the neurological disease. However, the risks such as demanding 
delicate surgical procedure and graft-induced complications may outweigh the benefits of the 
transplantation (Yu et al., 2013). Understanding the mechanisms of neural stem cell activation 
in the adult brain would provide an alternative source of stem cells for the repair of the 
damaged or injured brain, which could be less invasive. 
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6. Abbreviations:  
aNSC  Activated Neural Stem Cells 
b-gal Beta-galactosidase 
bHLH Basic helix-loop-helix 
BMP Bone morphogenetic protein  
bp Base pair 
BrdU 5-bromo-2-deoxyuridine  
Bv Blood vessel 
ChIP Chromatin immunoprecipitation 
CNS Central nervous system 
CSF Cerebrospinal fluid 
DAPI 4', 6-diamidino-2-phenylindole  
DAPT N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl 
ester 
DCX Doublecortin 
DG Dentate gyrus   
DIV Day in vitro 
Dll Delta-like 
EGF Epidermal growth factor 
EGFR Epidermal growth factor receptor   
FACS Fluorescence activated cell sorting  
FCS Fetal calf serum 
FGF Fibroblast growth factor 
GFAP Glial fibrillary acidic protein  
H Hour 
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HDAC Histone deacetylase complex 
Hes1/5 Hairy and enhancer of split-1/5 
KO Knock out 
LV Lateral ventricle 
Min Minute 
Mash1 (Ascl1)  Mammalian achaete-schute homolog 1 
NICD Notch intercellular domain 
NSC  Neural stem cell  
NPC Neural progenitor cell 
OB Olfactory bulb 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction   
PFA Paraformaldehyde  
PI Propidium iodide 
PIC Protease Inhibitor Cocktail II 
qNSC Quiescent neural stem cell 
RBPJ Recombining binding protein suppressor of hairless 
RMS Rostral migration stream 
RG Radial glia cell   
RT-PCR Real time-PCR 
S Second 
SGZ Subgranular zone 
SVZ  Subventricular zone 
SEZ Subependymal zone 
TAPs Transit amplifying cells 
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Tlx (Tll)  Tailless 
UTR Untranslated region 
WT  Wild type 
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